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NOMENCLATURE AND NUMBERING
The nomenclature that will be used when referring to homoisoflavonoid (la) and
stilbenoid (lb) structures in the discussion will be based on the numbering system
illustrated below. Any numbering system assigned to any other structures mentioned in
the text is the one derived from the primary literature.
Homoisoflavonoidal and stilbenoidal compounds mentioned in the text have been
numbered using counting numbers while non-homoisoflavonoidal and non-stilbenoidal
compounds have been numbered using counting numbers combined with the letter of
the alphabet, e.g. 2a, 2b, 2c, etc. The compounds isolated in this work will be numbered
using Roman numerals (i)-(xii)
Moreover the numbers allocated to homoisoflavonoids mentioned in the text are the













Bulbs of Scilla natalensis Planch, Scilla nervosa (Burch.) Jessop, Scilla dracomontana
Hilliard and Burt and Scilla kraussii Bak. (Hyacinthaceae) were investigated. The
plants are widely used by the local African people for a variety of ailments that inflict
them and their livestock.
Plant material was harvested in different localities i.e. KwaZulu-Natal (KZN) and
Mpumalanga (Mpl). The bulbs have been found to contain homoisoflavonoids and
stilbenoids. Ten homoisoflavonoids and two stilbenoids were isolated. Of the ten
homoisoflavonoids isolated, nine were of the 3-benzyl-4-chromanone type while one
was a 3-benzylidene-4-chromanone. Four of the 3-benzyl-4-chromanones were found to
be novel compounds while others were recognised as having been reported before from
other genera within the family Hyacinthaceae viz., Eucomis and Muscari. The 3-
benzylidene-4-chromanone type compound isolated was also found to be a known
compound. The stilbenoids, on the other hand, are reported for the first time in this
genus although they seem to have a wide distribution in the plant kingdom.

















Scilla nervosa (Burch.) Jessop







CHAPTER 2 : 13
HOMOISOFLAVONOIDS AND STILBENOIDS :
OCCURRENCE AND BIOSYNTHESIS
2.1 Homoisoflavonoids 14
2.1.20) The chalcone formation phase



















3.1 Structures of isolated compounds
3.2 Extractives from Scilla nervosa (Burch.) Jessop
3.2.1 Structural elucidation of compound (i)
3.2.2 Structural elucidation of compound (ii)







3.2.4 Structural elucidation of compound (iv) 51
3.2.5 Structural elucidation of compound (v) 53
3.2.6 Structural elucidation of compound (vi) 57
3.2.7 Structural elucidation of compound (vii) 60
3.3 Extractives from Scilla natalensis Planch. 63
3.3.1 Structural elucidation of compound (viii) 63
3.3.2 Structural elucidation of compound (ix) 67
3.4 Extractives from Scilla dracomontana Hilliard and Burtt. 70
3.4.1 Structural elucidation of compound (x) 71
3.4.2 Structural elucidation of compound (xi) 73
3.5 Extractives from Scilla kraussii Bak. 76
3.5.1 Structural elucidation of compound (xii) 76
3.6 Conclusion 79
CHAPTER 4 : EXPERIMENTAL 81
4.1 General 82
4.1.1 Melting points 82
4.1.2 Optical rotations 82
4.1.3 Infrared spectroscopy 82
4.1.4 Ultraviolet spectroscopy 82
4.1.5 Mass spectroscopy 82
4.1.6 NMR spectroscopy 82
4.1.7 Chromatography 83
4.2 Preparation and extraction of plant material 84
4.2.1 General extraction procedures 84
4.3 Extractives from Scilla nervosa 85
4.3.1 Physical data of compound (i) 87
4.3.2 Physical data of compound (ii) 88





Physical data of compound (iv)
Physical data of compound (v)
Physical data of compound (vi)






4.4 Extractives from Scilla natalensis
4.4.1 Physical data of compound (viii)
4.4.2 Physical data of compound (ix)
4.5 Extractives from Scilla dracomontana
4.5.1 Physical data of compound (x)
4.5.2 Physical data of compound (xi)
4.6 Extractives from Scilla kraussii
4.6.1 Physical data of compound (xii)
REFERENCES
APPENDIX A : Names of compounds in Table 2.1

















Humankind has harnessed the wonders and intrigues of nature since antiquity. The use
by man of many products from nature to either improve his lifestyle, ward off disease or
as a weapon in food gathering continues to this day. For instance, rotenoid containing
plants belonging to the genera Derris, Lonchocarpus, Piscidia and Tephrosia have long
been used by people in parts of South America, Tropical Africa and Asia as a fishing
tool 18, where roots or other plant parts are first crushed to release their active
compounds before being thrown into ponds or slow running streams. The ichthyotoxic
rotenoids, when released, rapidly stupefy any fish in the vicinity which subsequently
float to the surface where they are collected.
Moreover the popularity of traditional medicine, despite the advances in modem
medicine, among natives of different countries around the globe is a fact that no one can
deny. Cinchona bark has long been used by people in the tropics to treat malaria and
the chemical investigation into the active components of the extracts from these plants
has provided man with what we today know as anti-malarials, e.g. quinine 50.
Many drugs on the pharmaceutical market today are of plant or animal origin 50. Some
have been manipulated somewhat to increase their efficacy while at the same time
decreasing their toxicity and/or abuse potential. A case in point is that of lignocaine - a
wholly synthetic local anaesthetic drug modelled on cocaine from cocoa leaves
(Erythroxylum coca) 50, which is less addictive than cocaine.
Measures to bring traditional healers into the mainstream of health care in this country
need to be commended. This, it is hoped, will not only bring the secrecy under which
most healers prefer to operate to an end as their traditional mixtures will be open to
scientific scrutiny, but will also allow many people who rely on this type of health care
easy access as, it is hoped, medical insurance will be incorporated within. Although
there are success stories with regard to random screening e.g. taxol, much endeavour
should nevertheless be directed towards plants which have been used over many decades
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in folklore medicine, when searching for new drugs to fight many disorders that afflict
man up to this day.
Scilla natalensis Planch., S. nervosa (Burch.) Jessop, S. dracomontana Hilliard and Burt
and S. kraussii Bak. are four South African species in the family Hyacinthaceae
(previously under the family Liliaceae). Scilla nervosa and S. natalensis (sensu lato) are
two taxa which are widely used by the local African people for a variety of ailments that
'fl' h d h" I" k 3166-6972 78 I . f h' h h h' fIn lct t em an t elr Ivestoc ' ". t IS or t IS reason t at t e c emlstry 0
these particular species was investigated.
Previous investigations of the extracts from these species have revealed that they
possess anti-microbial properties against a wide range of pus forming organisms in vitro
and have anti-inflammatory properties 31. Previous studies on other plants falling under
this genus e.g. S. maritima, S. scilloides, S. indica and S. peruviana have revealed that
this genus is a source of triterpenoid (2a) 83 and cardiac (2b) 19 glycosides as well as a









Homoisoflavonoids are common in the family Hyacinthaceae and this lends them as
potential markers for taxonomy 17. Despite the fact that they have also been reported
outside the Hyacinthaceae, they are still a powerful taxonomic tool within this family in
that those appearing outside the Hyacinthaceae are distinct as most lack oxygenation at
the 5-position, e.g. bonducelin (59) and intricatin (62) from Caesalpinia bonducella





1.2 The genus Scilla (Hyacinthaceae)
o
intricatin (62)
Plants belonging to the genus Scilla L. have a wide distribution which extends
throughout Europe, Africa and Asia. There are about forty Scilla species, most of which
occur in Eurasia 65. Six species are found in southern Africa while several others occur
in tropical Africa 65. In southern Africa they are found mostly in the eastern parts of the
country, ranging from the Eastern Cape to Mpumalanga province including Lesotho and
Swaziland. The only species which is not found in this eastern belt is S. plumbea Lindl.
which is confined to the mountains of the South-Western Cape region 65. In southern
Africa, Scilla is an evergreen or summer growing genus. The species comprising this
genus are glabrous or pubescent geophytes characterised by bulbs situated below or
above the ground. The size and appearance of the bulbs varies considerably from
species to species.
Bulb scales of these plants are imbricate and some bulbs have an oblong hard woody
cortex with a fibrous neck. Roots are often hard and thick. Leaves may be smooth or
hairy, and are generally lance shaped or broad and arranged in a rosette 65. They bear
small blue, white or green coloured flowers in terminal racemes 31,
5
In addition to the species already mentioned Scilla firmifolia Bak. is also found in South
Africa. Notably, some taxonomists have, on the basis of bulb morphology, sunk S.
kraussi and S. dracomontana into S. natalensis 64,107.
1.3 Ethnobotany
Scilla plants are widely used medicinally by the local African people, for their own
health and that of their livestock. The same taxa have been reported to be toxic 71,73,78.
Traditional healers have used decoctions from these plants to treat rheumatism, venereal
. . . . 17 31 68 69 72 78dIseases, mental Illness and a vanety of other aIlments ' , , , , .
Of the four species forming part of this chemical investigation, only the use of S.
natalensis and S. nervosa in traditional remedies has been well documented 31,78. Scilla
kraussii which has been considered synonymous with S. natalensis 64, may have been
incorrectly identified in previous ethnobotanical studies.
Scilla natalensis, commonly known as inguduza, is one of the most heavily exploited
Zulu medicinal plants 73,75, with people interviewed at the herbal market claiming that
decoctions from this plant are also used to promote orgasm in men 66 in addition to
some of the well documented traditional uses 31,69,72,78. For example, the Zulu use
decoctions from S. natalensis, as ingredients in infusions taken to facilitate labour at
term 31. Although S. natalensis has been reported as toxic to sheep (resulting in
dyspnoea when ingested) 71 bulb preparations have been used by the locals to treat lung
sickness in cattle 31,78. The Sotho eat the cooked bulbs with food as an aperient, include
bulb decoctions in enemas to treat 'internal tumours' and rub powdered bulbs into
scarifications over sprains and fractures 68,78. The Tswana rub the powdered bulbs into
th~ back, joints and other body parts with the belief that it makes them strong and
resilient to witchcraft 69,78. The Swati apply a lotion prepared by boiling the macerated
bulbs in water, to boils and veld sores 78.
Scilla nervosa derives its name from one of its traditional medicinal applications, i.e.
relief of conditions of nervousness in children 78. In this regard, it is administered as an
enema prepared by mixing lightly boiled decoctions with fresh lukewarm milk 78, The
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Xhosa use the bulbs as a remedy for dysentery 78. Diluted bulb decoctions of S. nervosa
are also used in small, once daily doses as analgesics in rheumatic fever 31,78. The Sotho
use S. nervosa bulbs to treat gall sickness in their livestock, while crushed bulbs are
mixed with food and administered to children as an aperient 68,78. The Tswana use the
cooked bulbs, which are put into porridge and eaten three to four times a day for a
month, for the treatment of infertility in women 78.
Some Scilla spp. are used in Botswana for preventing witchcraft 69, by sprinkling the
whole yard with a mixture of crushed fresh bulbs and water while the Malawians living
in Kaluluma's area (Kasangu district) use a gluey substance called ulimo from Scilla
. 67spp. as an Illsect trap .
1.4 Scilla species in this study
1.4.1 Scilla natalensis Planch.
Scilla natalensis is found mainly III the province of KwaZulu-Natal (Fig.I.l). Its
. I k 31common name IS sang op .
The bulb is about 60-65 cm in diameter, 8 cm in length and is covered with brown
membranous leaf bases. Its leaves are uniformly green and hairy at times and are about
14 cm long and 4 cm broad at the base. The inflorescence, whose length reaches 35 cm,
is erect and rigid and bears deep blue and occasionally white flowers 71,108.
1.4.2 Scilla nervosa (Burch.) Jessop
This species is one of the most widely distributed Scilla species on the subcontinent,
(Fig. 1.2). Synonyms include Schizocarphus gerrardii, Schizocarphus nervosus
Schizocarphus rigidijolius and Schizocarphus acerosus 119-121. Locally, the Zulu people
11 " . 31ca It zngczno .
The bulbs are oblong in shape and vary in size (about 2-5 cm in diameter and 3 cm in
length) depending on the provenance. This was evidenced with the morphology of the
plant material collected in Lydenburg District, Mpumalanga, and that purchased at the
Warwick Triangle herbal market in Durban, KwaZulu-Natal. The bulbs are covered by
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a dense coat of fibrous material, a feature distinct to this species. The slender leaves are
about 10 cm long and 2-3 cm wide. The inflorescence is somewhat longer than the
leaves and bears white flowers with bluish-green anthers 3],52.
1.4.3 Scilla dracomontana Hilliard and Burtt.
Scilla dracomontana, whose distribution is far more restricted than S. natalensis
(Fig.1.3), is characterised by having small bulbs up to 3 cm in diameter and 5 cm in
length. As its specific epithet implies, it occurs in the Drakensberg mountains. Its
range in the Drakensberg extends from Giant's Castle (Estcourt District) to the upper
Umzimouti Valley (Underberg District). It occurs at altitudes of between 1675 and
2100m above sea level 74. It grows on sandstone cliffs, in rock crevices and on
hardpacked earth, often forming extensive colonies. Scilla dracomontana is
distinguished from both S. natalensis and S. kraussii in having its leaves fully developed
and flat on the ground at flowering time, whilst its larger relatives possess erect
immature leaves when the flowers open 74.
1.4.4 Scilla kraussii Bak.
Scilla kraussii possesses bulbs which are about 2 cm in diameter and 4.5 cm long,
covered by a thin layer of dead leaves. The plant has a solid butt below the bulb which
is about 1 cm long and 2 cm in diameter 51. Plants produce about four leaves; each of
these are rigid and have deep green and blackish-purple upper and lower surfaces
respectively. Leaves are generally about 7 cm in length and 1 cm wide. They are
convex above with an acute longitudinal furrow, pilose on both surfaces, with hairs
mainly along the nerves. Scilla kraussii is prevalent in Northeast Pondoland near
Nkambati and Umtamvuna Rivers close to Port Edward. This species is also found in
various parts of KwaZulu-Natal (Fig 1.4) 51.






















Fig. 1.1. Distribution ofScilla natalensis Fig. 1.2. Distribution ofScilla nervosa
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Fig. 1.3. Distribution ofScilla dracomontana Fig. 1.4. Distnoution of Scilla kraussii
Fig. 1.5. Scilla natalensis growing on a hill in Rella Rella
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Fig. 1.6. Scilla nervosa (harvested plant material)
10
11
Fig. 1.7. Scilla dracomontana growing on rock crevices in the Bamboo mountain







Homoisoflavonoids are a small group of natural compounds which are restricted in their
distribution, having been previously reported to occur mainly in genera in the
Hyacinthaceae 1-9,17,31,56. However, some of these homoisoflavonoids have also been
reported to occur outside this family, as reported earlier for example bonducellin (59)
and intricatin (62) 21,33. Within the Hyacinthaceae, members of the genera Scilla,
Eucomis and Muscari have been the most dominant with regard to the production of
homoisoflavonoids 1-4,17,56,59-62. Other Hyacinthaceous genera from which these
compounds have been reported are Bellevallia 5, Chionodoxa 7, Ophiopogon 35,37 and
Veltheimia 87. A number of representatives of the family Dracaenaceae, e.g. Dracaena
cinnabari 10, Dracaena draco 22 and Dracaena loureri 32 have also been reported to
possess homoisoflavonoids.
Homoisoflavonoids differ from the ubiquitous isoflavonoids by having a sixteen carbon
skeleton instead of the fifteen characteristic of the isoflavonoids. This sixteen carbon
skeleton bears either a chromane, chromone or chromanone moiety to which is attached,
in most cases, a benzyl or benzylidene grouping at the 3-position 15. A fourth ring is
present in the brazilin (6) 15,17, scillascillin (13) 15,17, and dracaenone type compounds 32
e.g caesalpin J (29). Substituents in the form of hydroxy, methoxy, acetoxy and in some
cases methyl and aldehydo groups can occur 14,15,47,56.58. These compounds were first
reported to occur in Eucomis species in 1967, eucomin (51) being one of the first
compounds to be isolated and characterised from Eucomis bicolor 62. Within the plant
these compounds have been found to be concentrated in the waxy layers between the
storage leaves of the bulbs 17.
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Previous studies have revealed that these compounds possess anti-inflammatory, anti-
. l' d . b . 1 . 17323388mutagenIC, ana gesIc an antI- actena propertIes . , . .
Table 2.1 represents a list of known, naturally occurring, homoisoflavanoids and
biogenetically related compounds. Due to space constraints within the table, the list of
names is provided in Appendix A. The nomenclature adopted is the one used in the
primary literature. Where no such nomenclature is available, systematic nomenclature
as used in Chemical Abstracts 113 has been adopted. The compilation of the list was
aimed at investigating which of the homoisoflavonoids isolated in this work had been
reported before.
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H OH (6) 11,17,44,56,58
H OCH3 (7) 44,56,58












H OH OH (9) 17,58
H OH OCH3 (10) 17,56,58,62
H OCH3 OCH3 (11) 17,26,56,58










H OH (13) 6,17,23,56,58
OH OCH3 (14) 7,17,56,58







I >~ g 0RI
OH 0
RI R2 R3
CH3 H H (16) 37,48,56,58
H CH3 H (17) 37,38,56,58
CH3 CH3 H (18) 35,37,47,56,58
CH3 CH3 OH (19) 47,56
CHO CH3 H (20) 14,56
H CH3 OH (21) 48,56









RI R2 R3 R4
OH OH OH OCH3 (23) 44,56
OH OH OH H (24) 1l,44,56
OCH3 OH OH OH (25) 41,45,46,56
OCH3 OH OH H (26) 45,56






















RI R2 R3 R4
OH OCH3 OH OH (29) 32,39,56
H H OH OCH3 (30) 32,56
OH H OH OCH3 (31) 32,56
RI I:t;ti'l R3
~OH 0
RI R2 R3 R4
OH H OH OCH3 (32) 3,56,58
OCH3 H OH OH (33) 4
OCH3 H OCH3 OH (34) 4
OH H OCH3 OH (35) 4













RI R2 R3 R4
CH3 H H OCH3 (37) 37,56,58
CH3 CH3 H OCH3 (38) 35,56,58
H H H OH (39) 47,56
CH3 H H OH (40) 47,56
CHO CH3 H OCH3 (41) 14,56











RI R2 R3 ~
CH3 OH H H (43) 37,38,48,56
CH3 OH CH3 H (44) 35,47,56,58
CHO OH CH3 H (45) 47,56,58
CHO OCH3 CH3 H (46) 56,58
CH3 OH CH3 OH (47) 47,56
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RI R2 R3 R4
OCH3 OH OH H (48) 10,56










RI R2 R3 R4 Rs R6
OH H OH H OH H (50) 56,58,59
OH H OH H OCH3 H (51) 56,58,62
OH H OH OCH3 OH H (52) 7.56,58,59
OH H OH OCH3 OCH3 H (53) 56,58.59,60
OH OCH3 OH H OH H (54) 56,58.60
OH OCH3 OH H OH OH (55) 7,12,56
OCH3 H OH H OH OH (56) 12,56
OH H OCH3 OH OH OH (57) 5,56
OH H OH OCH3 OH OH (58) 7,56
H H OH H OCH3 H (59) 8,21,56
H H OH OCH3 OCH3 H (60) 8,56
H H OH OH OCH3 H (61) 33,56
H H OCH3 OH OCH3 H (62) 11,33,56
H H OH H OH H (63) 11,56
H H OH H OH OH (64) 11,41,45,56
OH H OCH3 H OCH3 H (65) 26,58
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RI R2 R3 It. Rs R6
H H OH H H OH (66) 22,56,58
H H OAc H H OAc (67) 22,56
OH H OH H H OH (68) 22,56
OCH3 H OH H H OH (69) 56.59,60
OH H OH H H OCH3 (70) 26,56,58
OH H OCH3 H H OCH3 (71) 26,56
OH H OH H OH OeH3 (72) 2,4,56,58
OH CH3 OH H H OH (73) 22,56
OH CH3 OH H H OCH3 (74) 56,58
OH CH3 OH CH3 H OCH3 (75) 35.47.56,58
OH OCH3 OH H H OH (76) 56,58,61
OH H OCH3 OH H OH (77) 1,56,58
OH H OCH3 OAc H OH (78) 3.56,58
OH H OH OCH3 H OH (79) 1,3,56,58
OH H OCH3 OCH3 H OH (80) 1.3,56,58
OH H OH OCH3 H OCH3 (81) 56,58,60
OH OCH3 OCH3 OH H OH (82) 2,56,58
OH CHO OH CH3 H OCH3 (83) 47.56.58
OH CHO OCH3 CH3 H OCH3 (84) 56,58
OH OH OCH3 OCH3 OH OH (85) 5,56
OH OCH3 OH H OH OH (86) 4,56
OH OCH3 OH H OCH3 OH (87) 4,56
OH OCH3 OH H OH OCH3 (88) 4,56
OH H OCH3 OH OH OH (89) 4,56
OH H OH H OH OH (90) 4,56
OCH3 H OH H OH OH (91) 4.56
H H OH H OH OH (92) 41,56
OH OCH3 ocIl3 OCH3 H OH (93) 56,87
OCH3 H OH H OH OCH3 (94) 4,56
OH H OH OCH3 OH OCH3 (95) 7.56
OH CH3 OCH3 OCH3 OH OH (96) 48.56
H OH OCH3 H OH OCH3 (97) 56,110
OH H H H OH OH (98) 5,56




















2.1.2 Biosynthesis of homoisoflavonoids
Homoisoflavonoids are phenolic compounds, hence they can be synthesised by either or
both of two common biosynthetic routes leading to phenolic compounds: i.e. the
shikimate pathway starting from carbohydrates, and the polyketide pathway from acetyl
and malonyl CoA units 27-29. Homoisoflavonoids are of mixed origin with ring B
shikimate~derived and ring A polyketide-derived 9. In this discussion the processes
leading to homoisoflavonoid biosynthesis will be divided into two phases, viz.:
(i) the chalcone formation phase and
(H) the 3-benzyl(idene)-4-chromanone formation phase.
22





















Enzymes: A- L-phenylalanine ammonia lyase
B - cinnamate 4-hydroxylase
C - 4-coumarate Co ligase
D - chalcone synthase
E - methyl transferase
Scheme 2.1. The chalcone formation phase 24,29.
Scheme 2.1 represents the events leading to 2'-methoxychalcone formation. The entry
point for this pathway is the conversion of shikimate derived L-phenylalanine to
cinnamic acid in a reaction catalysed by the enzyme L-phenylalanine ammonia lyase 24.
This involves the elimination of ammonia in an antiperiplanar fashion to yield (Z)-
cinnamic acid. Subsequent hydroxylation of cinnamic acid, mediated by the enzyme
cinnamate-4-hydroxylase results in the formation of 4-coumaric acid. Cinnamate
hydroxylation occurs via a distinctive shift called the Nlli shift (National Institute of
Health in Bethesda, where it was discovered) 29. According to this shift, the proton in
the para position gives way to the OH group, being itself moved to the meta position.
The Nlli shift which was established by tritium (T) labelling experiments is depicted in
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scheme 2.2 below. Further hydroxylation, without the NIH shift, leads to the 3,4-
dihydroxy (catechol) pattern 29.
The 4-coumaric acid formed via the NIH shift is converted further to its CoA ester (4-
coumaryl CoA) by the enzyme 4-coumarate: CoA ligase. The 4-coumaryl CoA
molecule combines with three malonyl CoA derived acetate units. The CoA ester
resulting from this combination cyclises, presumably in a Claissen type condensation to
yield tetrahydroxychalcone. The enzyme chalcone synthase acts as a catalyst in this
transformation 29. Methionine, probably as S-adenosylmethionine, a common
methylating agent in living systems, provides the methyl group that gives 4,4',6'-tri-









Scheme 2.2. Hydroxylation of cinnamic acid to 4-coumaric acid via the NIH shift 29.
2.1.2 (ii) The 3-benzyl(idene)-4-chromanone formation phase (Scheme 2.3)
Scheme 2.3 is a summary of possible routes leading to 3-benzyl-4-chromanone and/or 3-
benzylidene-4-chromanone derivatives, with 2'-methoxy-4,4' ,6' -trihydroxychalcone (i)
from scheme 2.1 as the entry level intermediate.
24
A close examination of this scheme proposed by P.Dewick 9 sees a methoxy group being
used to create a carbon-carbon bond i.e. the C2, C3 bond. This phenomenon is not rare
in flavonoid chemistry as it has been demonstrated before in connection with the
biosynthesis of rotenoids e.g. rotenone (2c) from 2'-methoxyflavones 24. Moreover"
berberine bridge" formation via cyclisation of N-methyl groups has been reported in
alkaloid biosynthesis (scheme 2.4) 30. Furthermore, the co-occurrence of the chalcone
sappanchalcone (2d), together with a variety of homoisoflavonoids in Caesalpinia
sappan 11,41, gives credence to scheme 2.3. Although the chalcone oxonium and/or
carbonium ion is suggested as the potential intermediate in this phase, a radical version














Scheme 2.4. Berberine from reticuline, in which the N-methyl furnishes the extra
carbon atom of the" berberine bridge" 30.
The relationship between 3-benzyl(idene)-type structures and their variants as suggested
in scheme 2.3 has, nevertheless, not been fully established. Some workers maintain that
the /13,9 compounds arise from 3,9-dihydro relatives by way of their 3-hydroxylated
derivatives: [scheme 2.3: (v)~ (vi)~ (iv)] 9,17.
Another variation III the basic skeleton is to be seen in scillascillin, brazilin and
dracaenone type compounds. Scillascillin carries an extra 3-spirocyclobutene ring,
brazilin a cyclopentene ring whilst dracaenone-type structures like caesalpin J have an
extra cyclohexene ring. Scillascilloid and brazilloid structures have been postulated to
arise by way of activated intermediates (x) and (y) as represented in scheme 2.5 9.
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The co-occurence of 4-0-methylsappanol (25) and sappanol (27) with brazilin (6) in



















One other hypothesis for the formation of scillascilloid structures was suggested by
Bhandari and co-workers 24. Their study was on formation of rotenoids lacking the 3-
oxygenation, e.g. Irispurinol (2e) from Iris spuria (Iridaceae). The 3-oxygenated
rotenoids are characteristic of rotenoids emanating from the Papilionoideae division of
the Fabaceae 24. They hypothesised that these 3-deoxo rotenoids arise by way of the
oxonium and carbocationic intermediates as depicted in scheme 2.6. From this scheme,
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they extended the hypothesis to the formation of scillascilloid compounds from 3-












Scheme 2.6. Hypothesis for the formation of rotenoids lacking 3-hydroxylation 24.
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H0WJ)0"':: OH HO~O17 OH HOWJfO17 OH
I I - I O~ - I + OH
:::::,... Q :::::,... ~ H :::::,... Q
R 0 R 0 R 0
3-benzylchromanoid
scillascilloid
Scheme 2.7. Hypothesis for the formation of scillascilloids from 3-benzyl-4-
chromanones 24.
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With regard to dracaenone type-compounds, they have been hypothesised to arise from
3-benzylchroman-type compounds by way of cyclisation via para-para phenolic
oxidative coupling to a tetracyclic intermediate 32. This intermediate then undergoes
thermal suprafacial 1-+5 sigmatropic hydrogen migration to the dracaenone skeleton as
represented in scheme 2.8. The co-occurence of 10-hydroxy-ll-methoxydracaenone
(30) and 7,10-dihydroxy-ll-methoxydracaenone (31) with 7-hydroxy-3-(4-
hydroxybenzyl)chroman (1) in Dracaena loureiri 32, suggested that its close relative 7-
hydroxy-3-(3-hydroxy-4-methoxybenzyl)chroman (48) isolated from a sister species









10-hydroxy-ll-methoxydracaenone (30) R =H







Scheme 2.8. Biogenesis of dracaenone-type homoisoflavonoids 32
In summary, scheme 2.3 suggest that homoisoflavonoidal compounds are synthesized by
modification of the C6.C3.C6 chalcone-flavanoid skeleton by insertion of an extra
carbon atom from the 2'-methoxy group of 2'-methoxychalcone. In this scenario, a
C6.C3 unit from phenylalanine is incorporated intact into the 3-benzyl-4-chromanone
skeleton, becoming C-4,C-3,C-9 and the aromatic ring B, whilst another C6 unit
comprising ring A is acetate/malonate (polyketide) derived. O-methylation as supplied
by methionine provides the the C-2 of the heterocyclic ring C. Because of scheme 2.3,
the name homoisoflavonoid has been dubbed a misnomer in that homoisoflavonoids are
not formed by any step involving a 2,3-aryl shift (scheme 2.9) as is the case with
isoflavonoids. The name benzylchromanoid which was subsequently coined is not
correct either, especially in the light of dracaenone and comosin (5) type structures.
Thus the term homoisoflavonoid, although "inappropriate and misleading" 58, had been















Stilbenoids have a wide distribution in the plant kingdom and have been previously
reported from the following families: Poaceae 95,102, Vitaceae 55,97,103, Pinaceae 98,
Myristicaceae 91, Polygonaceae 89,91,93, Fabaceae 96,98,101, Melanthiaceae 94 and
Cyperaceae 100. There have been no previous reports of stilbenoids in the genus Scilla.
The isolation of stilbenoids from Scilla in this work represents the first report of these
compounds not only in this genus but in the family Hyacinthaceae although they have
been reported in the closely related family Melanthiaceae, previously included in the
L'l' ( l) 941071 laceae sensu ato ' .
Stilbenoids have been isolated from wood, bark, leaves, seeds, stems and pods of the
plants concerned and they occur either as free compounds or their glycosides. In some
cases e.g. Veratrum grandiflorum 94 and Arachis hypogea 96 they have been found to be
released in response to external stress stimuli. In such cases they act as phytoalexins,
being a defence mechanism on the part of the plant. The formation of resveratrol dimers
and trimers in grape (Vitis vinifera) has been linked to disease resistance as resveratrol






2.2.2 Biosynthesis of stilbenoids
Scheme 2.10 below is a representation of a pathway leading to stilbenoid biosynthesis. It
is evident from this scheme that stilbenoids are also synthesised from the same
cinnamoyl CoAlmalonyl CoA substrates that lead to homoisoflavonoid production via
the same polyketide and shikimate pathways. The difference lies in the fact that, in
stilbenoid synthesis, the enzyme-bound polyketide is folded differently and a
d b 1 · d' 1" 104105 Th . 1 d' 'lbecar oxy atlOn occurs unng cyc IsatlOn' e enzyme mvo ve IS stI ene
synthase. Since stilbenoids, like resveratrol (104), behave as phytoalexins that possess
anti-fungal properties in some plants, the transfer of the gene coding for stilbene
synthase to other plants lacking it should result in phytoalexin synthesis and subsequent
enhanced disease resistance. This has been carried out by some workers where the gene
from grape (Vitis vinifera) was transferred to tobacco plants which were later able to





























Enzyme 1: stilbene synthase
2: chalcone synthase




3.2 Structures of isolated compounds
OCH3
CH30 OCH3 HO OH






























i ii iii iv v vi vii viii ix x xi xii
S. nervosa a X X X X X X
S. nervosa b X X
S. natalensis a X
S. natalensis b X
S. dlmontana X X X
S. kraussii X
Chart 2
a _ KwaZulu-Natal specimen
b _ Mpumalanga specimen
Chart 1 is a representation of the compounds isolated from the Scilla specIes
investigated in this work while Chart 2 gives an indication of which compounds have
been isolated from the different species.
The following compounds are compounds which are going to be mentioned in the






















The 3-benzyl-4-chromanone structure (Fig. 3.1) of compounds (i), (ii), (iii), (iv), (viii),
(ix), (x) and (xii) was deduced from the appearance in their I H NMR spectra [Table
3.1] of the signals due to the -(2)CH2-(3)CH-(9)CH2- grouping. These were observed as
a pair of double doublets within the chemical shift range: 4.10--4.32 ppm [AB of ABX,
(2)CH2], one multiplet in the range: 2.72- 2.87 ppm [(3)CH] and two double doublets in
the ranges: 2.65-2.73 ppm and 3.10-3.26 ppm [(9)CH2] respectively. These chemical
shifts agreed well with literature values 4 for 3-benzyl-4-chromanones. A COSY
spectrum of compound (i) was run and it confirmed the expected coupling between
these signals [spectrum 3]. Moreover, the long wave absorption maxima (Amax)
recorded in the DV spectra for the 3-benzylchromanoids was in agreement with
literature expectations as they ranged from 282 to 293nm while literature values lie
between 285 and 290 nm 17.
The 3-benzylidene-4-chromanone (i.e. L13,9) structure (Fig. 3.2) of compound (v) was
inferred from the appearance of the signals at 85.35 ppm and 87.77 ppm in the I H NMR
spectrum [spectrum 32a and 32b] corresponding to 2H-2 and H-9 respectively, and
these were in agreement with the literature 5,7,12,17. In addition Amax was found to be 362
nm and this was also in agreement with what one would expect given the literature
values of between 358 to 367 nm for this system 17.
The stilbene nature (Fig 3.3) of compounds (vi) and (vii) was derived from comparison
with literature data 89,90,92,96,116.
The molecular formulae of the compounds isolated were derived from molar masses
determined by high resolution mass spectrometry (hrms). The formula: db =2m + 2 -
n/2 was used to derive the double bond equivalence (db) based on the molecular
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formula, where m stands for the number of carbon atoms and n for the number of
hydrogen atoms in the molecular formula. The db formula is based on the notion that
the presence of oxygen as the heteroatom in the molecules neither adds nor reduces the
109number of hydrogen atoms .
o
Fig. 3.1. 3-benzyl-4-chromanone Fig. 3.2. 3-benzylidene-4-chromanone
Fig. 3.3. stilbenoidal structure
Tables 3.1 and 3.2 are a summary of the IH and 13C NMR data for isolated
homoisoflavonoids while Tables 3.3 and 3.4 presents IH and 13C NMR data for
stilbenoids. Use was made of reported literature values 1-7.12,15,16,17,90,100,116 in the
compilation of the tables. In addition, other tabular comparisons with literature values
have been provided in the discussion where appropriate. All numerical values in
parentheses in the I H NMR tables in this section and subsequent sections are coupling
constants in Hz.
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Table 3.1. IH NMR (300MHz, CD30D, TMS as internal standard) data of
homoisoflavonoidal compounds. All chemical shift (8) values are expressed in ppm.
Cpd 2H-2 H-3 H-6 H-8 2H-9 H-2' H-6' H-3' H-5' Other signals
(i) 4.11,4.29 2.72 6.20d 6.15d 2.68dd 7.17d 6.89d 3.80s 5-0CH3#
m (9.8, 12.6) 3.86s 7-0CH3#
AB of ABX AB AA'BB' AA'BB' 3.86s 4'-OCH3#
(3.8, 6.6, 11.4) (2.4) 3.IOdd (8.7) (8.7)
(3.6, 12.6)
(ii) 4.14,4.31 2.87 6.07d 6.03d 2.67dd 6.75d 6.71dd - 6.89d 3.84s 7 -OCH3
m (10.2,13.8) (2.1) (2.1) (8.1) 3.86s 4'-OCH3
AB ofABX AB (8.1)
(4.2,7.2, 11.4) (2.4) 3.10dd
(3.6, 13.8)
(iii)lj> 4.15,4.32 2.82 6.23d 6.18d 2.72m 7.3 Id 7.07d 2.30s 4'-OAc
m 3.86s 5-0Me
AB of ABX AB 3.16m AA'BB' AA'BB' 3.86s 7-0Me
(4.2,7.2, 11.4) (2.4) (8.4) (8.4)
(iv) 4.13,4.31 2.88 6.07d 6.03d 2.72dd 7.19d 6.90d 3.84s 7-0CH3
m (9.9, 13.5) 3.81s 4'-OCH3
AB ofABX AB AA'BB' AA'BB'
(4.2,7.2, 11.4) (2.1) 3.17dd (8.7) (8.7)
(4.5,13.8)




(viii) 4.10,4.26 2.83 - 5.94s 2.67dd 7.09d 6.78d 3.81s 6-0CH3
m (10.2, 13.5)
ABofABX AA'BB' AA'BB'
(4.2,7.2, 11.4) 3.13dd (8.4) (8.4)
(4.2,13.8)
(ix) 4.10,4.2 2.84 - 5.95s 2.66dd 6.75d 6.70dd - 6.89d 3.86s 4'-OCH3
m (10.2, 13.5) (2.1) (2.1) (8.1) 3.81s 6-0CH3
AB of ABX (8.1)
(4.2,7.2, 11.4) 3.lldd
(4.5, 13.5)
(x) 4.10,4.27 2.85 - 5.95s 2.73dd 7.19d 6.90d 3.81s 4'-OCH3
m (9.9, 13.5) 3.81s 6-0CH3
AB of ABX AA'BB' AA'BB'
(4.5,6.9, 11.4) 3.26dd (8.7) (8.7)
(4.5, 13.5)
(xi) 4.08d - 5.95d 5.92d 2.96d 7.20 6.88 3.81s 4'- OCH3
3.92d (3.3)
(11.4) AB AA'BB' AA'BB'
(2.1) (8.7) (8.7)
(xii) 4.11,4.28 2.82 5.91d 5.88d 2.65dd 6.75d 6.71dd 6.89d 3.87s 4'- OCH3-
m (10.2,13.5) (2.1) (1.8) (8.1 )
AB of ABX AB (8.1)
(4.2,7.2,11.4 ) (2.1) 3.lldd
(4.5, 13.8)
Note: This table has been compiled by comparison to the literature 1-7,12,15
# - values interchangeable
(iii)~ - compound (iii) acetate
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Table 3.2. BC NMR data of homoisoflavonoidal compounds (75MHz, CD30 D, TMS as
internal standard). All chemical shift (8) values are expressed in ppm.
C (i) (ii) (iii)~* (iv) (v) (viii) (ix) (x) (xi)* (xii)*
2 70.1 70.4 70.1 70.4 68.6 70.3 70.3 70.3 72.9 70.4
3 S S S S 127.0 S S S 73.5 S
4 193.9 199.8 193.7 199.8 186.5 200.2 200.1 200.1 199.8 199.4
4a 106.1 103.6 106.1 103.8 103.8 103.1 103.0 103.0 101.4 102.9
5 164.0 165.6 164.1 165.6 164.0 156.9 156.8 156.5 164.4 165.8
6 93.8 95.9 93.9 95.8 97.4 130.2 130.5 131.4 97.6 97.1
7 168.0 169.4 168.1 170.0 169.4 160.5 160.8 160.7 168.9 168.3
8 94.6 94.6 94.6 94.6 96.0 95.9 95.8 95.8 96.3 95.9
8a 166.6 164.6 166.7 164.6 160.7 160.1 160.1 160.1 160.3 164.7
9 33.3 33.1 33.4 32.9 138.0 33.0 33.2 32.9 40.7 33.1
l' 131.8 132.3 130.5 131.4 128.4 130.2 132.3 131.4 128.2 132.4
2' 131.1 117.1· 131.2 131.2 133.6 131.2 117.1· 131.2 132.8 117.1·
3' 115.0 147.9~ 122.9 115.1 116.8 116.4 147.9~ 115.1 114.5 147.9~
4' 159.9 147.7~ 137.7 160.0 160.7 157.3 147.7~ 160.0 160.3 147.7P
5' 115.0 113.0· 122.9 115.1 116.8 116.4 113.0· 115.1 114.5 113.0·
6' 131.1 121.4 131.2 131.2 133.6 131.2 121.4 131.2 132.8 121.4
5-0CH3 56.3 - 56.3 - - - - - - -
6-0CH3 - - - - 61.0 61.0 61.0 - -
7-0CH3 56.2 56.5 56.3 55.7 - - - - - -
4'-OCH3 55.7 56.3 56.3 - - 56.5 55.7 55.7 56.5
4'-OAc 171.4 a
20.9 b
Note : The chemical shift data in Table 3.2 has been compiled with reference to
literature 1-7,13,15,16,57
., P- values are interchangeable; ~ - signal hidden under solvent peaks
a _ resonance due to the carbonyl group; b - resonance due to the methyl group
* - data collected at 125 MHz using a Varian Innova 500 MHz instrument
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Table 3.3. IH NMR data of stilbenoidal compounds (300MHz, CD30D, TMS as
internal standard). All chemical shift (8) values are expressed in ppm.
Cpd H-2 H-4 H-6 H-7 H-8 H-2' H-6' H-3' H-5' Other
(vi) 6.48d 6.19t 6.48d 6.86d 6.97d 7.39d 6.80d -
(2.1) (2.1) (2.1) (16.2) (16.2) AA'BB' (AA'BB')
(8.7) (8.7)
(vii) 6.48d 6.20d 6.48d 6.95d 6.82d 7.04d 6.97dd - 6.93d 3.90s
(2.1) (2.1) (2.1) (16.5) (16.5) (1.8) (1.8) (8.7) 4'-OMe
(8.7)
Table 3.4. 13C NMR data of stilbenoidal compounds (75 MHz, CD30D, TMS as
















4'- OCH3 - 56.4
Note: data in Tables 3.3 and 3.4 collated with reference to the literature 89-91,97,116
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3.2 Extractives from Scilla nervosa (Burch.) Jessop
From the hexane and chloroform extracts of S. nervosa bulbs (KZN) compounds (i) and
(ii) were isolated while compounds (Hi), (v), (vi) and (vii) were isolated from the ethyl
acetate extract. Compounds (i) and (iv), were isolated from the hexane extract of S.
nervosa (Mpl).
3.2.1 Structural elucidation of compound (i)
compound (i)
Compound (i) was found to have a molar mass of 328.1311 g.mor l (calculated
328.1306 g.mor l ). The molecular formula CI9H200S was deduced. From the molecular
formula a double bond equivalence of 10 was deduced using the formula mentioned in
section 3.1 above.
The IH NMR spectrum [spectrum 1] revealed that compound (i) had three methoxy
groups. Substitution in ring A was deduced from mass, IH NMR and DV spectra. The
presence of two methoxy groups in ring A was deduced from the occurrence of peaks at
m/z 180 and 181 in the mass spectrum [spectrum 4] due to retro-Diels-Alder (RDA)
cleavage and hydrogen shift of a chromanone fragment at m/z 207, which was itself
generated by an A-4 type cleavage of the molecular ion [Scheme 3.1] 17. The hydride
shift from C-2 to ring A which results in the peak at m/z 181 is a well known behaviour
of flavonoids in general 17. The absence of free 5-hydroxy and 7-hydroxy groups was
also deduced from the fact that no bathochromic shifts were observed in the DV spectra
in the presence of AIC!) and NaOAc respectively [spectra 7 and 8] 1,2,29. The
. appearance of the H-6 and H-8 resonances downfield of 6.0 ppm [Tables 3.1], lends
further support to the presence of a methoxy group C-7, as these protons absorb upfield
of 6.0 ppm in the case of a free hydroxy group at C-7 15. In the I3C NMR spectrum
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[spectrum 2] the chemical shift 8193.9 ppm due to the carbonyl carbon at C-4 was
noticed to be significantly upfield of the norm (the norm being close to 8200 ppm)
relative to other homoisoflavonoids having a free 5-hydroxy group [Table 3.2]. The
absence of the chelation between the 5-hydroxy group and the C-4 carbonyl group
should explain the upfield shift of the C-4 resonance in this compound because the
chelation imparts a deshielding effect on the carbonyl group. The carbon chemical shift
value assigned to C-4 agreed well with those of other homoisoflavonoids having a
methoxy substituent at C-5 4,6.
With regard to substitution in ring B, the appearance of an AA'BB' system revealed a
para disubstituted benzene ring [spectrum 1 and Table 3.1]. The presence of a
methoxy group as the 4' substituent in this ring, was revealed by the presence of an
intense peak at m1z 121 in the mass spectrum [spectrum 4], corresponding to a
methoxybenzyl/tropylium ion as represented in scheme 3.1.
OCBJ 0
m/z328












Scheme 3.1. Fragmentation pattern of compound (i) 17
[Scheme 3.1 serves as a representative scheme for related compounds]
The 1H NMR data of compound (i) was compared to the literature data 26 for a synthetic
analog [Table 3.5]. It became evident from this comparison that the resonances as well
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as respective coupling constants correlated well although data was recorded in CDCh in
the case of the synthetic compound.
The carbon resonances presented in Table 3.2 were assigned by comparison with
reported chemical shift values for other homoisoflavonoids 1-7,15. The allocation of
chemical shifts to ring A carbons in particular, was done in comparison with a synthetic
scillascillin type compound (104) having a similar ring A substitution pattern to that
suggested for compound (i) 6 [Table 3.6] because no 13C NMR data for simple 3-
benzyl-4-chromanones with the same substitution pattern could be found in the
literature. From these results it was concluded that compound (i) was 5,7-dimethoxy-3-
(4-methoxybenzyl)chroman-4-one, a novel compound.
Table 3.5. I H NMR data of compound (i) compared to literature
Proton(s) (i) (CD30D) (i) (CDCI3) 26
2H-2 4.11,4.29 4.13,4.31







2H-9 2.68dd, (9.8, 12.6) 2.70m










# - values can be mterchanged
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compound (i)
Table 3.6. 13C NMR data of compound (i) and (106)
compound (106)





















~ - hidden under solvent peaks
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3.2.2 Structural elucidation of compound (ii)
OH 0
compound (ii)
Compound (ii), was found to have a molar mass of 330.1092 g.mor l (calculated
330.1093 g.mor l ). This was consistent with the molecular formula C18H1806. A double
bond equivalence of 10 was deduced.
The I H NMR spectrum of compound (ii) was found to be very similar to that of
compound (xii) isolated from Scilla kraussii [spectra 9 and 87 and Table 3.7]. The
differences were that two methoxy groups appeared in the spectrum of compound (ii) in
contrast to one for compound (xii). Moreover, the H-6 and H-8 proton signals appeared
downfield of 6.00 ppm whereas those for (xii) appeared upfield of 6.00 ppm [Table
3.7]. Based on this comparison, it was presumed that compound (ii) was a methylated
derivative of the known 2,15 compound (xii)[72]. Table 3.7 also lists the literature I H
NMR data of this known compound (xii) [72] 2.15. To prove this assumption the mass,
DV and proton spectra were analysed closely. The mass spectrum [spectrum 12]
revealed peaks at m1z 193, 166 and 167 corresponding to A-4, RDA and H-shift
fragments. This gave an indication that ring A of compound (ii) carried one methoxy
and one hydroxy group. A bathochromic shift (+24 nm) with AlCh [spectrum 15] and
no shift with NaOAc [spectrum 16] in DV spectral measurements were indicative of a
5-hydroxy-7-methoxy substituted ring A. Furthermore, the appearance of the resonance
due to H-6 and H-8 protons downfield of 6.00 ppm was also an indication of the
presence of a methoxy group at C-7 15.
The I H NMR spectrum revealed an aromatic ABX system [86.89 ppm (d, J =8.1 Hz,
H), 86.71ppm (dd, J =2.1,8.1 Hz, IH), 86.75 ppm (d, J =2.1 Hz, 1H)] [Table 3.7] thus
giving a clue that ring B was trisubstituted. One methoxy group and one hydroxy group
were attached to this ring as revealed by the presence of a base peak at m1z 137
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corresponding to a hydroxy- methoxybenzyl/tropylium ion in the mass spectrum. The
position of the methoxy group in this ring was deduced from NOE experiments. Upon
irradiation of the doublet at 86.89 ppm [spectra Ba and Bb], a positive NOE effect
was observed for one of the methoxy group proton signals at 83.86 ppm and the double
doublet signal at 86.71 ppm. From this result it was concluded that the signals at 86.89
ppm and 83.86 ppm were due to H-5' and protons of the methoxy group at 4' position
respectively. The double doublet signal centred at 86.71 ppm was assigned to H-6'.
Table 3.7. I H NMR data of compounds (ii) and (xii)[72]
Proton(s) (ii) (CD3OD) (xii) (CD3OD) (72) [xii] 15(CD3OD)
2H-2 4.14,4.31 4.11,4.28 4.06,4.23
ABofABX AB of ABX AB of ABX
(4.2,7.2, 11.4) (4.2,7.2,11.4) (4.4, 7.3, 11.4)
H-3 2.87m 2.82m 2.78m
H-6 6.07d 5.91d 5.86d
AB AB AB
(2.4) (2.1) (2.2)
H-8 6.03d 5.88d 5.83d
AB AB AB
(2.4) (2.1) (2.2)
2H-9 2.67dd, (10.2, 13.8) 2.65dd, (10.2, 13.5) 2.60dd, (10.3, 13.6)
3.lOdd, (3.6, 13.8) 3.l1dd, (3.6, 13.8) 3.06dd, (4.0, 13.6)
H-2' 6.75d, (2.1) 6.75d, (2.1) 6.70d, (1.8)
H-5' 6.89d, (8.1) 6.89d, (8.1) 6.84d, (8.1)
H-6' 6.71dd, (1.8, 8.1) 6.71dd, (1.8, 8.1) 6.66d, (1.8, 8.1)
7-0CH3 3.84s - -
4'-OCH3 3.86s 3.87s 3.82s
The carbon shift assignments [Tables 3.2] were made with comparison to literature data
especially relative to those reported for compound (xii) [72] 4,15. Noteworthy in this
comparison [Table 3.8], were the chemical shifts due to C-6 and C-8. In compound (ii)
these carbons have been assigned shifts which are 1.2 ppm downfield to those of
compound (72). This has to be expected if one bears in mind what Adinolfi and co-
workers 15 found regarding the effect a methoxylated C-7 has on the chemical shifts of
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the two artha carbons, i.e. 'the resonances of the unsubstituted C-6 and C-8 should
appear at 97.1-97.3 and 95.8-96 ppm respectively when C-7 carries a hydroxy group,
and at higher field (-1,3 ppm), when C-7 carries a methoxy group'. For C-6, this means
one substracts 1.3 from 97.1 to get 95.8 ppm, and the value allocated to C-6 is equal to
95.9 ppm. The same applies to C-8 where a value of 94.6 ppm has been assigned and
this is in good agreement with the expected value of 94.5 ppm if one takes Adinolfi and
co-workers' substituents effects into consideration.
From this analysis it was concluded that compound (ii) was the 7-0-methyl derivative of
the known compound (72) 2,4. It was thus concluded that compound (ii) was 5-hydroxy-
7-methoxy-3-(3-hydroxy-4-methoxybenzyl)chroman-4-one, a novel compound.
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Table 3.8. 13C NMR data of compound (ii) and (72)



















~ - hidden under solvent peaks
-, p- values can be interchanged




This compound was isolated after an acetylation step (Chapter 4) due to its co-elution
with other compounds despite the use of different solvent systems. The discussion of its
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structure is based on its acetyl derivative since there were only minute amounts
available preventing deacetylation. The acetyl derivative had a molar mass of 356.1270
g.mor1 (calculated 356.1260 g.mor') corresponding to the molecular formula C2oH2006.
A double bond equivalence of 11 was deduced.
The IH NMR spectrum [spectrum 17] revealed that compound (Hi) acetate had two
methoxy groups (s, 3.86 ppm, 6H) and one acetyl group (s, 2.30 ppm, 3H). The
resonances due to H-6 and H-8 were observed to be downfield of 6.00 ppm [Table 3.1]
implying that one of the methoxy groups was at C-7 '5. The absence of bathochromic
shifts in the DV spectrum with NaOAc and AIC!) sugested the presence of either a
methoxy or acetoxy group at the 7- or 5-position [spectra 23 and 24. The nature of the
substitution pattern in ring A was gathered from the mass spectrum [spectrum 20]. The
appearance of relatively intense peaks at m/z 180 and 181 due to RDA and H-shift
fragmentations similar to those for compound (i) as presented in scheme 3.1, gave
evidence of the existence of a dimethoxy substituted ring A. The I3C NMR spectrum
also revealed a similar situation as in compound (i) with regard to the chemical shift of
the carbonyl group at C-4 in that this shift occurred at b193.7 ppm relative to those
which are very close to b200.0 ppm in cases where this group is under the influence of a
deshielding chelation from the neighbouring 5-hydroxyl group [Table 3.2]. The
resonances assigned to ring A carbons were assigned with comparison to those of
compound (i) [Table 3.9]. In the I3C NMR spectrum of compound (Hi) acetate there
were signals which were asribed to the breakdown product of the acetate and these have
been crossed in the spectrum [spectrum 18].
Substitution in ring B was deduced from the appearance of an AA'BB' system in the 'H
NMR spectrum. The downfield location of these signals when compared to other
homoisoflavonoids having a 4'-hydroxy or 4'-methoxy group in this ring [Table 3.1]
was an indication that the acetoxy group was attached at the 4'-position. A peak at m/z
152 in the mass spectrum corresponding to an acetoxybenzyl ion was also evidence for
the 4' derivative. From these results it was concluded that the original compound (Hi)
was 5,7-dimethoxy-3-(4-hydroxybenzyl)chroman-4-one, a novel compound.
Table 3.9. l3C NMR data of compound (i) and (iii)






















~ - hidden under solvent peaks
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3.2.4 Structural elucidation of compound (iv)
OH 0
compound (iv)[71]
Compound (iv) , was found to have a molar mass of 314.1154 g.mor l (calculated
314.1158 g.mor l ) corresponding to the molecular formula C18H1805. A double bond
equivalence of 10 was deduced.
This compound was found to be the known compound 7-0-methyl-3,9-dihydroeucomin
(71), which was previously reported in Eucomis bicolor 17,26. The long wave absorption
maximum in the DV spectrum was located at 288 nm (log E 4.43) [spectrum 29] while
the literature value was 288.5 (4.306) 26.
The I H NMR spectrum [spectrum 25] revealed that compound (iv) had two methoxy
groups. Substitution in ring A was deduced from mass, proton and DV spectra. The
existence of a hydroxy group at C-5 was revealed by a bathochromic shift (+23 nm) in
the DV spectrum with AlC!) [spectrum 30]. No shift was observed with NaOAc
[spectrum 31] suggesting that a methoxy group occurred at C-7, an observation which
was also corroborated by the appearance of resonances due to H-8 and H-6 downfield of
6.00 ppm [Table 3.1] IS. In the mass spectrum [spectrum 27], the presence of low
intensity peaks at m/z 166 and 167 corresponding to RDA and H-shift fragments of the
chromanone ion also confirmed this substitution in ring A.
Substitution in ring B was deduced from the appearance of the AA'BB' system signals
[Table 3.1] in the I H NMR spectrum indicating that it was para disubstituted. The
methoxy group was the substituent in this ring as revealed by the presence of a base
peak at m/z 121 corresponding to a methoxybenzylltropylium ion.
The IH NMR data of compound (iv) was finally compared to literature data [Table
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3.10] where it was found that the literature values correlated very well with the
experimental values. Since there was no l3C NMR data available in the literature 26 for
this compound the carbon resonances in Table 3.2 were assigned with comparison to
data for other homoisoflavonoids. From these results and comparison it was concluded
that compound (iv) was indeed the known 5-hydroxy-7-methoxy-3-(4-
methoxybenzyl)chroman-4-one (7-0-methyl-3,9-dihydroeucomin) (71).
Table 3.10. IH NMR data of compounds (iv) and (71)
Proton(s) (iv) (CD3OD) (71) (CDCh) 26
2H-2 4.13,4.31 4.12,4.28
ABofABX ABofABX
(4.2, 7.2, 11.5) (4.2,6.5, 11.5)
H-3 2.88m 2.80m
H-6 6.07d, (2.1) 6.06, (2.3)
H-8 6.03d, (2.1) 5.97, (2.3)
2H-9 2.72dd, (9.9, 13.5) 2.80m














Compound (v) was assigned the molecular formula CI6H120 5 based on the molar mass
of 284.0678 g.mor l (calculated 284.0685 g.mor'). A double bond equivalence of 11
was deduced.
The presence of a 3-benzylidene (i.e. a 3(9)-unsaturated) system was inferred from the
appearance of the signals at 85.35 ppm, (d, J =1.8 Hz, 2H-2) and 87.71 ppm (t, J =1.8
Hz, H-9) in the I H NMR spectrum [spectrum 32a, 32b and Table 3.1] as well as
appearance of a resonance corresponding to an a,~-unsaturated carbonyl group carbon
atom at 8186.5ppm in the l3C NMR spectrum [spectrum 33, Table 3.2] 5,7,16,17. The
COSY spectrum [spectrum 34] confirmed the coupling between 2H-2 and H-9.
Furthermore the DV spectrum exhibited an absorption maximum at 362 nm (log E 4.36)
and this is typical of 3(9) unsaturated homoisoflavonoids 17,26.
The mass spectrum [spectrum 35] revealed peaks at m/z 153, 152, 132 and 107. The
base peak at m/z 107 which was thought to be a hydroxybenzyl ion was unexpected
given previous reports on the fragmentation of these compounds as presented in scheme
3.2 17. The mass spectral fragments at m/z 152 and 153 indicated two hydroxy groups
attached to ring A. These were at the 5 and 7 positions as confirmed by bathochromic
shifts in the DV spectra with both AICh (+40 nm) and NaOAc (+12 nm) respectively
[spectra 39 and 40]. Moreover appearance of the H-6 and H-8 signals in the IH NMR
spectrum at chemical shifts of 85.93 ppm and 85.87 ppm was also an indication of a
hydroxy group at C-7 IS.
The substitution pattern in ring B was deduced from the appearance of the fragment at
m/z 132 in the mass spectrum corresponding to the RDA fragment ion as depicted in
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scheme 3.2, as well as the appearance in the I H NMR spectrum of an aromatic AA'BB'
system indicating the occurrence of a para disubstituted benzene ring [Table 3.1].
There have been conflicting reports in the literature regarding the configuration at C-9.
Some reports claim the appearance of the 2H-2 and H-9 signals as a doublet and triplet
respectively [spectrum 32b] are indicative of the (Z)-geometry at this double bond due
1· 512 h'l hi' h . 1726 NOE .to long range coup mg' w I e ot ers c aIm t e OppOSIte . . expenments were
performed to confirm which conformation was correct. Molecular models were
constructed for both geometric isomers (E and Z) before the NOE experiments were
performed. The model for the (Z)-isomer revealed that H-9 was close to 2H-2, H-2' and
H-6' and this meant that one should get positive NOEeffects for signals due to these
protons if H-9 was irradiated [Fig. 3.4]. The model for the (E)-isomer revealed that only
H-2' and H-6' were close to H-9 and this meant that one should get positive NOE effect
for the H-2' and H-6' signals only if H-9 was irradiated [Fig. 3.5].
Irradiation of the triplet (appearing as broad singlet in spectrum 32a) at 87.77 ppm (H-9)
led to a positive NOE effect of the doublet signal at 87.30 ppm only [spectrum 36a].
This supported the (E)-configuration of the 3(9)-double bond as the doublet at 7.30 ppm
has been assigned to H-2' and H-6' [Table 3.1]. To provide further evidence for the
(E)-geometry, the doublet at 85.35 ppm (2H-2), was irradiated and this led to a positive
NOE effect of the doublet at 87.30 ppm (H-2'/H-6') only [spectrum 36b]. Finally, the
doublet at 87.30 ppm (H-2'/H-6') was irradiated [spectrum 36c] and this resulted in a
positive NOE effect of the doublet at 86.92 ppm (H-3' and H-5'), the triplet at 87.77
ppm (H-9) and the doublet at 85.35 ppm (2H-2). This last NOE result provided
evidence that the geometry at the 3(9)-double bond was (E) as these results would not be
expected in the case of a (Z)-isomer. The positive NOE response of H-2' and H-6' to























m/z 152 m/z 153
Scheme 3.2. Fragmentation pattern of compound (v) 17
The IH NMR data of compound (v) was compared with literature data for (Z)- and (E)-
eucomin as no data for (E)-4'-O-demethyl eucomin was available in the literature 59.
The literature referred to the data for eucomin as being comparable to that for
demethyleucomin 59. In Table 3.11, it may observed that data for (E)-eucomin
correlates well with that of compound (v). Finally, the l3C NMR data of compound (v)
was compared with that of eucomin (51) [Table 3.12] because no l3C NMR data for
demethyleucomin (50) could be found in the literature 59. From this analysis and
comparisons it was concluded that compound (v) was the known compound (E)-4'-0-
demethyleucomin (50) which was isolated previously from Eucomis punctata 59.
Table 3.11. IH NMR data* of compounds (v) and (51)
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Proton(s) (v) (CD3OD) (51) (E) (CDC1)) 26 (51) (Z) (CDC1)) 26
2H-2 5.35d, (1.8) 5.31d, (1.7) 4.91s
H-6 5.93d 6.00 5.99
AB AB AB
(2.2) (2.3) (2.3)
H-8 5.87 5.90 5.93
AB AB AB
(2.2) (2.3) (2.3)
H-9 7.77t, (1.8) 7.80t, (1.7) 6.87s
H-2'1H-6' 7.30d 7.27 7.81
AA'BB' AA'BB' AA'BB'
(8.7) (8.8) (8.8)
H-3'1H-5' 6.92d 6.96 6.90
AA'BB' AA'BB' AA'BB'
(8.7) (8.8) (8.8)
4'-OCH3 - - 3.85s
* -data for compound (v) recorded in a 300 MHz spectrometer




(E)-eucomin (51) (Z)-eucomin (51)
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Table 3.12. l3C NMR data for compound (v) and (51)






















Compound (vi) was found to have a molar mass of 228.0784 g.mor l (calculated
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228.0786 g.mor l ) corresponding to the molecular formula C14H1203. A double bond
equivalence of 9 was deduced.
The l3C NMR spectrum [spectrum 42] revealed 10 signals as one would expect given
the chemical equivalence between carbons in the following pairs: C-3, C-5; C-2, C-6; C-
2', C-6'; C-3', C-5'. The chemical shifts [Table 3.4] were assigned with comparison to
literature values 90,91,97.
The presence of an A2B system in the I H NMR spectrum [b6.48 ppm (d, 1 =2.1 Hz, 2H)
and b6.19 ppm (t, 1 =2.1 Hz, 1H)] [spectra 41a and 41b] gave a clue to the occurrence
of a 1,3,5-(resorcinol-type) trisubstituted ring A of a stilbenoid 89,91. The protons were
meta coupled to each other as the magnitude of the coupling constant (J = 2.1 Hz)
suggested. This coupling was confirmed by the COSY spectrum [spectrum 43]. A
trans olefinic bond within the molecule was revealed by the appearance in the I H NMR
spectrum of two doublets coupled to each other at b6.86ppm (l = 16.1 Hz) and b6.97
ppm (J = 16.1 Hz) [spectra 41b and 44]. The magnitude of the coupling constant
'd' d 9097III lcate a trans geometry , .
Ring B was found to be a para disubstituted benzene ring from the appearance in the
proton spectrum of signals corresponding to an AA'BB' system [Table 3.4]. These
signals were in agreement with literature values 89. The I H NMR data of compound
(vi) was finally compared with literature 89 values for resveratrol (104) [Table 3.13].
Since no l3C NMR data for resveratrol was available in the literature 89,94.95, the data of
resveratrol-3-0-g1ucoside (piceid) (107) 97, was compared with the data for resveratrol
[Table 3.14]. Only the data due to the aglycone part of the molecule is quoted for
piceid in Table 3.14. The close similarity between these values observed from the two
tables led to the conclusion that compound (vi) was (E)-resveratrol (104) a known
naturally occurring stilbenoid previously isolated from the roots of Polygonum
cuspidatum (Polygonaceae) 89, the dried rhizomes, stressed leaves of Veratrum
grandiflorum (Melanthiaceae) 94, and the seed of Festuca versuta (Poaceae) 95, in grapes
(Vitis vinifera) and wine 55,97.
Table 3.13. IH NMR data of compound (vi) and (E)-resveratrol (104)
Proton(s) (vi) (CD3OD) (104) (Me2CO-d6) 89
H-2 / H-6 6.48d, (2.1) 6.53d, (2.0)
H-4 6.19t, (2.1) 6.25t, (2.0)
H-7 6.86d, (16.2) 6.87d, (16.5)
H-8 6.97d, (16.2) 7.01d, (16.5)
H-2' / H-6' 7.39d 7.41d
AA'BB' AA'BB'
(8.7) (8.5)












Table 3.14. l3C NMR data of compounds (vi) and (107) aglycone















3.2.7 Structural elucidation of compound (vii)
OH
compound (vii)[105]
Compound (vii) was found to have a molar mass of 258.0903 g.mor1 (calculated
258.0892 g.mor
1
) corresponding to the molecular formula ClsH1404. A double bond
equivalence of 9 was deduced. The substitution pattern in both ring A and ring B was
inferred from NOE experiments, the proton and carbon spectra.
The IH NMR spectra of compound (vii) was related to that of compound (vi) but
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differed in the presence of one methoxy group and the appearance of a 1,3,4-(catechol-
type) substitution in ring B [spectra 41a, 41b, 48a, 48b and Tables 3.3]. The
resorcinol-type substitution pattern in ring A was still the same as in compound (vi).
NOE experiments were carried out to determine the substitution pattern in ring B.
Irradiation of the methoxy group proton signal at 83.90 ppm resulted in a positive NOE
effect of the doublet at 86.93 ppm (l = 8.7 Hz, H-5') [spectrum 51a]. This result meant
that the methoxy group was in close proximity to H-5' and this could only happen if the
methoxy group was at the 4' position. Moreover since there was no enhancement of any
other proton resonance, this meant that the hydroxy group in this ring was adjacent to
the methoxy group i.e. it was at the 3' position. Further NOE experiments were carried
out to verify the substitution. Irradiation of the doublet at 87.04 ppm (l = 1.8 Hz)
resulted in a positive NOE effect of the signals corresponding to the olefinic protons
only [spectrum SIb]. This implied that the doublet at 87.04 ppm (J =1.8 Hz) was due
to H-2' and the two doublets centred at 86.95 ppm and 86.82 ppm (J = 16.2 Hz) were
due to H-7 and H-8 respectively 114. Irradiation of the doublet centred at 86.82 ppm
resulted in a positive NOE effect of the signal at 87.04 ppm (d, 1 = 1.8 Hz) and 86.48
ppm (J = 2.1 Hz) [spectrum SIc]. The enhancement of the signal at 6.97 ppm, (dd, 1 =
1.8, 8.7 Hz) due to H-6' could not be detected despite being expected as a result of the
free rotation across the C-l', C-8 bond 114. This may be due to the close proximity of
6.97 ppm to 6.82 ppm which led to the signals being affected in the NOE experiment
[spectrum SIc]. The results of the latter NOE experiment indicated that the doublet at
86.82 ppm was due to H-8 while those at 87.04 ppm and 86.48 ppm were due to H-2'
and H-2/H-6 respectively 114. A molecular model of compound (vii) revealed that the
olefinic H-8 was in close proximity with H-2', H-6' (free rotation across C-l', C-8
bond), H-2 and H-6 (the proximity of H-2 to H-8 is due to the free rotation of the C-l,
C-7 bond) 114. Comparison of the IH NMR data of compound (vii) with literature data
of the known rhapontigenin (105) 116 showed a close correlation in chemical shift values
as well as coupling constants [Table 3.15], with minor differences attributable to
solvent effects. Hence it was concluded that compound (vii) was rhapontigenin (105).
However the 13C NMR spectrum [spectrum 49] showed 15 'major' signals two of
which were unaccounted for, as one would expect to get 13 signals for rhapontigenin
(vii) [105] as some of its carbons are chemically equivalent e.g. C-2 and C-6 as well as
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C-3 and C-5. The peaks which could not be accounted for are marked with a cross in
spectrum 49. The literature 13C NMR data of an aglycone part of rhaponticin (108) • a
rhapontigenin glycoside - was used to compare with the assignments made for
compound (vii) since complete I3C NMR data of rhapontigenin was not found in the
literature 116. From this comparison, a close correlation in the respective assignments
emerged thus indicating that compound (vii) was rhapontigenin (105). From these
observations it was concluded that compound (vii) was indeed rhapontigenin (105)
previously isolated from Rheum undulatum 56 and Rhei rhizoma 116, both species being
members of the family Polygonaceae.
Table 3.15. I H NMR data of compounds (vii) and rhapontigenin (105)
Proton(s) (vii) (CD3OD) (105) (Me2CO-d6) 116
H-2 6.48d, (2.1) 6.56d, (2.0)
H-4 6.20t, (2.1) 6.29t, (2.0)
H-6 6.48d, (2.1) 6.56d, (2.0)
H-7 6.95d, (16.2) 7.02d, (16.0)
H-8 6.82d, (16.2) 6.84d, (16.0)
H-2' 7.04d, (1.8) 7.09d, (2.0)
H-5' 6.93d, (8.7) 6.88d, (8.0)







Table 3.16. 13C NMR data of compounds (vii) and (108) aglycone
C (vii) (CD3OD) (108) aglycone















4'- OCR3 56.4 55.5
# - values are interchangeable
3.3 Extractives from Scilla natalensis Planch.
Compound (viii) was isolated from the methanol extract of S. natalensis (KZN) while
compound (ix) was isolated from the hexane and ether extracts of S. natalensis (Mpl).




Compound (viii), was found to have a molar mass of 316.0945 g.mor l (calcd. 316.0947
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g.mor 1) corresponding to the molecular formula C17HI606. A double bond equivalence
of 10 was deduced.
This compound was found to be the known compound 3,9-dihydroeucomnalin [5,7-
dihydroxy-6-methoxy-3-(4-hydroxybenzyl)chroman-4-one] (76) which was previously
isolated from Eucomis autumnalin 61. The DV spectrum [spectrum 59] exhibited an
absorption maximum at 290 nm (log E 4.63) while the literature value was reported to
be 292 nm (log f: 4.61) 61.
The IH NMR spectrum showed the presence of one methoxy group (s, 83.81 ppm, 3H).
The appearance in the mass spectrum [spectrum 57] of peaks at m1z 209, 183 and 182
corresponding to A-4 and RDA fragments gave an indication that two hydroxy groups
and one methoxy group were attached to ring A while the base peak at m/z 107 was
indicative of a hydroxybenzyl moiety and hence a hydroxylated ring B. The
arrangement of substituents on ring A was deduced from DV experiments and by
comparison of carbon chemical shift data [spectrum 56 and Table 3.18] to literature 15
values.
Bathochromic shifts in DV spectral measurements with AIC!) (+22 nm) [spectrum 60]
and NaOAc (+37 nm) [spectrum 61] were indicative of hydroxy groups at C-5 and C-7
respectively. The methoxy group in ring A could be placed at either C-6 or C-8 since
both C-5 and C-7 were shown to be carrying hydroxy groups. In order to locate the
position of the methoxy group in this ring, the carbon chemical shift data of the known
3,9-dihydroeucomnalin (76) and 3,9-dihydropunctatin (79) 15 were compared with that
of compound (viii) [Table 3.18]. In this comparison particular emphasis was placed on
resonances due to C-5, C-6 and C-8 (highlighted in bold in the Table 3.18). The
chemical shift assigned to C-5 of compound (viii) was 156.9 ppm and this was to be
expected given Adinolfi and co-workers' 15 assertion that this carbon should resonate at
about 9.0 ppm upfield from the norm (the norm being 165.8 ppm in case of a 5,7
dihydroxy substituted ring A) when there is a methoxy group at C-6 [165.8 -156.9 =8.9
ppm]. Moreover, the norm regarding C-6 and C-8 is appearance of their shifts in the
ranges 97.1-97.3 and 95.8-96.0 respectively in cases where there is a hydroxy group at
C-7 15. Since 895.9 ppm, a value assigned to C-8 in compound (viii), was outside the
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range 97.1-97.3 (a range for unsubstituted C-6) this implied that the unsubstituted
position in this ring should be C-8. It was concluded from this comparison that the
methoxy group was at C-6.
Substitution in ring B was inferred from the appearance of an intense peak at m/z 107 in
the mass spectrum corresponding to a hydroxybenzyl/tropylium ion as well as the
aromatic AA'BB' system signals in the IH NMR spectrum [spectrum 55 and Table
3.17]. From this information it was concluded that ring B was a para disubstituted
benzene ring. Finally the IH NMR data of compound (viii) was compared to the
literature data of 3,9-dihydroeucomnalin (76) [Table 3.17]. The close correlation
observed in Table 3.17 together with other results in this discussion led to the
conclusion that compound (viii) was indeed 3,9-dihydroeucomnalin (76).
Table 3.17. IH NMR data of compound (viii)[76]
Proton(s) (viii) (CD3OD) (76) 15(CD3OD)
2H-2 4.10,4.20 4.00,4.17
AB of ABX AB of ABX
(4.2,7.2, 11.4) (4.3,7.7, 11.4)
H-3 2.83m 2.75m
H-8 5.94s 5.89s
2H-9 2.67dd, (10.2, 13.5) 2.59dd, (10.6, 13.0)















Table 3.18. l3C NMR data of compounds (viii)[76] and (79)
C (76) I5(CD3OD) (viii) (CD3OD) (79) I5(CD3OD)
2 70.5 70.3 70.2
3 49.1 ~ 48.0
4 199.9 200.2 199.3
4a 102.7 103.1 102.8
5 156.7 156.9 161.0
6 130.4 130.2 97.2
7 161.1 160.5 161.6
8 95.9 95.9 130.1
8a 160.0 160.1 155.6
9 32.9 33.0 33.1
.
I' 130.0 130.2 129.8
2' 131.0 131.2 131.1
3' 116.3 116.4 116.4
4' 157.1 157.3 157.1
5' 116.3 116.4 116.4
6' 131.0 131.2 131.1
6-0CH3 60.9 61.0
8-0CH3 61.5
~ - hIdden under solvent peaks
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3.3.2 Structural elucidation of compound (ix)
compound (ix)[88]
Compound (ix) was found to have a molar mass of 346.1044 g.mor1 (calculated
346.1052 g.mor1) corresponding to the molecular formula ClsHlS07. A double bond
equivalence of 10 was deduced.
The IH NMR spectrum showed that compound (ix) had two methoxy groups (s, B3.81
ppm, 3H and s, B3.86 ppm, 3H) [spectrum 62]. Substitution in ring A was deduced
from DV experiments, the mass and IH NMR spectra. Although a number of expected
fragments due to RDA fragmentation 4 could not be detected in the mass spectrum
[spectrum 64], the presence of a low intensity peak at mlz 209 corresponding to a
dihydroxy-methoxychromanone fragment ion was testimony to the existence of a ring A
with two hydroxy and one methoxy groups. Th~ appearance of a singlet integrating for
one proton at B5.95 ppm (normally due to H-8/H-6) in the IH NMR spectrum was also
an indication that there was only one unsubstituted position in ring A. The fact that this
chemical shift was upfield of 6.0 ppm provided evidence that a hydroxy group occurred
at C-7 15. This was confirmed by a bathochrornic shift (+36 nm) with NaOAc
[spectrum 69]. A hydroxy group also occurred at C-5 because a bathochromic shift
(+23 nm) was recorded with AIC!] [spectrum 68]. The position of the methoxy group
was determined by comparing carbon chemical shift data of compound (ix) with
literature data of known compound (88) [Table 3.20] 4. The comparison followed the
same trend as in compound (viii) in terms of comparing carbon shift data for C-5,C-6
and C-8. It was concluded from this comparison that the methoxy group was at C-6
due to the close similarity between carbon shifts due to compound (ix) and those of
known compound (88) 4.
Ring B was found to be trisubstituted as revealed by the appearance of an aromatic ABX
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system III the proton spectrum. A base peak at m/z 137 in the mass spectrum,
corresponding to a hydroxymethoxybenzyl ion indicated that ring B contained one
hydroxy and one methoxy substituent. Despite the similarity in chemical shifts for this
ABX system with those of compound (ii)[Table 3.1] and other related 3',4'-oxygenated
compounds 4,13,15,57 thus suggesting a similar substitution pattern, a NOE experiment
was performed for confirmation. Irradiation of the singlet at 83.86 ppm (OMe) led to
the positive NOE effect of the doublet at 86.89 ppm, J = 8.1 Hz [spectrum 65a]. This
was an indication that the methoxy group was at the 4'-position because the signal at
86.89 ppm corresponded to H-5' [Table 3.19]. To provide an unambiguous proof of
this substitution, the doublet at 86.89 ppm was then irradiated. This irradiation led to
the positive NOE effect of the singlet at 83.86 ppm (OMe) and the double doublet at
86.70 ppm, J = 1.8, 8.1 Hz [spectrum 65b] thus providing enough evidence that the
methoxy group and H-6' were adjacent to H-5'. Irradiation of the doublet at 86.75 ppm
(J =2.1 Hz, H-2') led to the positive NOE effect of the signals corresponding to H-3 and
H-9 [spectrum 65c]. The double doublet signal for H-6' was also affected in this latter
NOE experiment due to its close proximity to the H-2' signal and this resulted in the
positive enhancement of the doublet at 86.89 ppm as well. The NOE experiment
suppoted the mass spectral results that only one methoxy group was attached to ring B.
The 1H and 13C NMR data of compound (ix) was finally compared to the literature data
of the known compound (88) and they correlated very well [Tables 3.19 and 3.20].
From this analysis it was concluded that compound (ix) was 5,7-dihydroxy-6-methoxy-
3-(3-hydroxy-4-methoxybenzyl)chroman-4-one (88), a known compound having been
previously isolated from Muscari armeniacum 4.
Table 3.19. IH NMR data of compound (ix)[88] compared to literature
Proton(s) (ix) (CD30D) (88) 4 (CD3OD)
2H-2 4.10,4.26 4.06,4.24




2H-9 2.66dd, (10.2, 13.5) 2.62dd, (9.9, 13.6)
3.11dd, (4.5, 13.5) 3.06dd, (4.8, 13.6)
H-2' 6.75d, (2.1) 6.71d, (1.8)
H-5' 6.89d, (8.1) 6.85d, (8.1)





Table 3.20. I3C NMR data for compound (ix)[88] compared to literature



















# - hidden under solvent peaks
3.4 Extractives from Scilla dracomontana Hilliard and Burtt.
Compound (x) was isolated from the hexane fraction while compounds (viii) and (xi)
were isolated from the ether fraction of the fresh bulbs extracts from this plant.
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Compound (x) was found to have a molar mass of 330.1100 g.mor1 (calculated
330.1103 g.mor1) corresponding to a molecular formula ClsHlS06. A double bond
equivalence of 10 was deduced.
The I H NMR spectrum [spectrum 70] showed that compound (x) had two methoxy
groups (s, 83.81 ppm, 6H). Substitution in ring A was deduced from DV experiments,
l3C and IH NMR spectra. The expected mass spectral fragments at mlz 209, 182, 183
could not be detected in the mass spectrum [spectrum 73] despite the appearance of the
base peak at mlz 121 which confirmed the occurrence of the A-4 fragmentation pattern
as depicted in scheme 3.1. This also meant that the other methoxy group must be
attached to ring A despite the non-appearance of the expected fragment ions. In the IH
NMR spectrum, the appearance of a singlet integrating for one proton at 85.95 ppm
(normally due to H-8/H-6) was proof that there was only one unsubstituted position in
ring A. The fact that this was upfield of 6.0 ppm provided evidence that a free hydroxy
group occurred at C-7. This was confirmed by a bathochromic shift (+36 nm) with
NaOAc [spectrum 77]. A bathochromic shift (+23 nm) with AICh [spectrum 76] gave
an indication that a hydroxy group occurred at C-5. The location of the methoxy group
in this ring was assigned with comparison to literature values 15 and with reference to
the chemical shift data of compound (viii) [Table 3.22]. The comparison followed the
same trend as in compound (viii) above. From this comparison it was concluded that
the methoxy group in this ring was at position 6.
NOE experiments were performed to locate the position of the other methoxy group on
the molecule. Since the two methoxy groups resonated at the same chemical shift i.e.
83.81 ppm in CD30D, the NOE specta were recorded in CDCh as the methoxy proton
72
resonances resolved into two separate peaks in this solvent. Irradiation of the methoxy
group proton signal at 83.89 ppm did not cause enhancement of any signal [spectrum
72a] while irradiation of the one at 83.77 ppm caused the enhancement of the doublet at
86.84 ppm corresponding to H-3' and H-5' [spectrum 72b]. This meant that the
resonance at 83.77 ppm was due to the methoxy group at the 4' position and this was
supported by the appearance of the base peak at m/z 121 in the mass spectrum
corresponding to the methoxybenzyl/tropylium ion. The appearance of signals due to an
AA'BB' system in the IH NMR spectrum [Table 3.1] was consistent with the presence
of a para disubstituted benzene ring B. From these results it was concluded that
compound (x) was a methylated derivative of 3,9-dihydroeucomnalin (76), i.e. 4'-0-
methyl-3,9-dihydroeucomnalin which has hitherto not been reported from nature.
Table 3.21. IH NMR data of compound (x) and (viii)
Proton(s) (x) (CD3OD) (viii) (CD3OD)
2H-2 4.10,4.27 4.10,4.20
AB of ABX ABofABX
(4.5,6.9, 11.4) (4.2, 7.2, 11.4)
H-3 2.83m 2.83m
H-8 5.95s 5.94s
2H-9 2.73dd, (9.9, 13.5) 2.67dd, (10.2, 13.5)










Table 3.22. 13C NMR data of compounds (x), (viii)[76] and 3,9-dihydropunctatin (79)
C (76) 15(CD30D) (viii) (CD3OD) (x) (CD3OD) (79) 15(CD3OD)
2 70.2 70.3 70.3 70.5
3 49.1 ~ ~ 48.0
4 199.9 200.2 200.1 199.3
4a 102.7 103.1 103.0 102.8
5 156.7 156.9 156.5 161.0
6 130.4 130.2 131.4 97.2
7 161.1 160.5 160.7 161.6
8 95.9 95.9 95.8 130.1
8a 160.0. 160.1 160.1 155.6
9 32.9 33.0 32.9 33.1
l' 130.0 130.2 131.4 129.8
2' 131.0 131.2 131.2 131.1
3' 116.3 116.4 115.1 116.4
4' 157.1 157.3 160.0 157.1
5' 116.3 116.4 115.1 116.4
6' 131.0 131.2 131.2 131.1
6-0CH3 60.9 61.0 61.0 -
8-0CH3 - - - 61.5
4'-OCH3 - - 55.7 -




Compound (xi) was found to have a molar mass of 316.0940 g.mor1 (calculated
316.0947 g.mor1) corresponding to the molecular formula C17H160 6. A double bond
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equivalence of 10 was deduced. A quartenary C-3 was inferred from the non-
appearance in the proton spectrum of the resonances attributed to the -(2)CH2-(3)CH-
(9)CH2- grouping. Furthermore the BC NMR spectrum revealed an extra C-O signal
(apart from methoxy group carbon resonance at 055.7 ppm and the C-2 resonance at
072.9 ppm ) at 073.5 ppm which, when compared to literature values, agreed with the
placement of a hydroxy group at C-3 16.
Substitution in ring A was deduced from 1H NMR, DV and mass spectra. The
appearance of an aromatic AB system corresponding to H-6 (05.92 ppm, d, J = 2.1 Hz)
and H-8 (05.92 ppm, d, J =2.1 Hz) in the I H NMR spectrum [spectrum 78] meant this
ring was substituted at the 5 and 7 positions. Bathochromic shifts with AICh (+22 nm)
[spectrum 85] and NaOAc (+38 nm) [spectrum 86] in the DV spectrum were
indicative of hydroxy groups at C-5 and C-7 respectively. The appearance of a fragment
at m/z 195 in the mass spectrum [spectrum 82], albeit at very low intensity 17,
corresponding to a 3,5,7-trihydroxy-4-chromanone fragment gave further evidence for
the presence of a 5,7-dihydroxy substituted ring A. A fragment expected to appear at
m/z 298 - corresponding to loss of one water molecule from the molecular ion - was,
however, not detected in the spectrum 17.
Substitution in ring B was deduced from the appearance in the 1H NMR spectrum of an
AA'BB' system [Table 3.1]. A methoxy group was placed at the 4' position due to the
presence of a fragment at m/z 121 (base peak) in the mass spectrum corresponding to a
methoxybenzyl/tropylium ion. Finally the I H and BC NMR data of compound (xi)
were compared to the literature data of eucomol (10) [Tables 3.23 and 3.24] 17,62.
From these results and comparison it was concluded that compound (xi) was eucomol
(10), a known compound which was isolated previously from Eucomis bicolor 62.
Table 3.23. IH NMR data of compound (xi) and eucomol (10)
Proton(s) (xi) (CD3OD) (10) (CDCh) 62



















Table 3.24. l3C NMR data for compound (xi) and eucomol (10)


















3.5 Extractives from S.kraussii Bak.
Compound (xii) was isolated from the ether extract of the bulbs of this species.
3.5.1 Structural elucidation of compound (xii)
OH 0
compound (xii)[72]
Compound (xii) was assigned the molecular formula C17H1606 based on the molar
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mass of 316.0952 g.mor l (calculated 316.0947 g.mor l ). A double bond equivalence of
10 was deduced
Comparison of the IH and l3C NMR spectra of compounds (xii) and (ii) [spectra 9
and 87 and Table 3.1] revealed a close similarity between the two except that (ii) had
two methoxy groups to one in (xii). The missing methoxy group in (xii) was found to
be the one at C-7 as revealed by the peak at m/z 179 in the mass spectrum [spectrum
90] corresponding to a 5,7-dihydroxychromanone fragment generated via A-4 cleavage
of the molecular ion. Further evidence that a hydroxy group was present at C-7 was
revealed by the appearance of chemical shifts due to H-6 and H-8 downfield of 6.0 ppm
i.e. at 85.92 ppm and 85.96 ppm. Bathochromic shifts with both AICl) (+23 nm)
[spectrum 93] and NaOAc (+35 nm) [spectrum 94] were also indicative of a 5,7-
dihydroxy substitution in ring A.
The IH NMR spectrum also revealed the presence of an aromatic ABX system
[spectrum 87 and Table 3.1] which indicated a trisubstituted ring B much the same as
in compound (ii). A NOE experiment [spectrum 89] which involved irradiation of the
singlet at 83.87 ppm (OMe) resulted in a positive NOE effect of the doublet signal at
86.89 ppm (H-5'). From these results, it was concluded that the methoxy group was at
the 4'-position. Since no other signal enhancement was observed, this meant the
hydroxy group in ring B was adjacent to the methoxy group i.e. it was at the 3' position.
The IH NMR and l3C NMR data for compound (xii) were compared to those of the
known compound 5,7-dihydroxy-3-(3-hydroxy-4-methoxybenzyl)chroman-4-one (72) IS
[Tables 3.7 and 3.25]. It was found from this comparison that the resonances and
respective coupling constants correlated very well. From this analysis and comparison it
was concluded that compound (xii) was 5,7-dihydroxy-3-(3-hydroxy-4-
methoxybenzyl)chroman-4-one (72), a compound previously isolated from Muscari
comosum 2.
Table 3.25. 13C NMR data of compound (xii)[72] compared to literature
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The presence of homoisoflavonoids in all Scilla species in this study was to be expected
. 1-712 IS 17 6162 f h d . hgIven the documented occurrence "", 0 t ese compoun s m t e
Hyacinthaceae. One notable feature distinguishing these from other homoisoflavonoids
isolated outside this family, is the 5,7-dioxy substitution pattern which has been found
lacking in most homoisoflavonoids emanating from other families 10,32.
Some of the homoisoflavonoids isolated from the Hyacinthaceae are of the eucornnalin
type i.e. they carry an extra methoxy group at C-6. Some workers have found the
presence of the extra oxygenated group at either C-6 (eucomnalin type) or C-8
(punctatin type) useful in the grouping of the species within a genus 17. Notable in this
work for the production of the eucomnalin type are S. natalensis and S. dracomontana.
This may provide a clue on the relationship between these two species especially in
view of the fact they were once sunk into one species i.e. S. natalensis 64,107. The
appearance of homoisoflavonoids in the sister genus Ledebouria 122, which has been
undergoing chemical investigation by one member of our group confirms that
homoisoflavonoids are widespread within the family Hyacinthaceae.
Stilbenoids, on the other hand, have been isolated for the first time from this genus.
Previous reports have revealed that purple-blue spots appeared on chromatograms of
extracts from other Scilla, Chionodoxa and Muscari species after they had been treated
with a number of spray reagents but these had not been characterised 17. Although
stilbenoids have been isolated from only S. nervosa in this work, it needs to be
mentioned that these purple-blue spots appeared in the chromatograms of all the species
studied but they were in much higher concentration in S. nervosa. Their significance in
this genus and the family cannot be a taxonomic one because stilbenoids have been
found in a vast array of genera which are not part of the Hyacinthaceae as alluded to in
section 2.2 (chapter 2). Their significance may be attributed to the ability of these plants
to colonise a variety of habitats as stilbenoids have been documented to possess
antifungal properties 94,96. For instance, the wide distribution of S. nervosa i.e. from
near-tropical KwaZulu-Natal extending to near-desert Botswana, could be attributed to
the production of these compounds in quantities enough to enable this species to thrive
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where others fail to grow. In other plants, stilbenoids have been reported to act as
phytoalexins 94,96 i.e. produced by the plant in response to stress (fungal attack or
physical damage to leaves, etc.).
Coming to potential ethnomedical benefits of the plants to their users, the appearance of
both homoisoflavonoids and stilbenoids in these Scilla species could provide support for
their ethnomedical usage. Homoisoflavonoids have been shown by some workers 88 to
possess anti-inflammatory properties by inhibiting croton oil induced dermatitis in
mouse ear and this inhibition was comparable to that of indomethacin, a potent non
steroidal anti-inflammatory drug. This could explain why the locals find these plants
beneficial in treating conditions that have an inflammation aspect e.g. fractures, boils
and veld sores 78. Furthermore, they have been found to possess anti-allergic, anti-
histaminic, anti-mutagenic and angioprotective properties in addition to being potent
phosphodiesterase inhibitors 87.
Stilbenoids, on the other hand, could also play a part in anti-inflammatory action by
virtue of being anti-oxidants. Inflammation processes are accompanied by the release of
highly reactive and toxic oxygen radicals. By acting as scavengers of these radicals,
stilbenoids could play a vital role in the anti-inflammation process. Moreover, recent
research 55,97 into the presence of resveratrol (104) and its glycosides in grapes (Vitis
vinifera) and red wines has been suggested to provide an explanation for the 'French
paradox' i.e. the epidemiological evidence that moderate consumption of red wine by
the French may counteract the effects of saturated fats prevalent in dairy and meat
products thus reducing predisposition to coronary heart disease (COO). This is because
of their anti-oxidant properties. Reports 97 have appeared recently linking the aglycone
in resveratrol glycosides in the inhibition of the copper (Cu 2+) catalysed oxidation of
human low density lipoprotein (LDL) and the aggregation of platelets, the two processes
which are a major cause of CHD in affluent societies and this has generated much






Melting points for crystalline compounds isolated were determined on a an Emst Leitz
Weltzlar melting point apparatus and are uncorrected.
4.1.2 Optical rotations
Optical rotations were recorded at room temperature in either methanol or chloroform
(depending on solubility) on an Optical Activity Ltd AA-5 automatic polarimeter. The
concentrations of the solutions are expressed in g /l00 rnI.
4.1.3 Infrared spectroscopy
The samples were run on NaCl discs and spectra recorded on a Mattison FTIR
spectrophotometer. Either chloroform or methanol was used as solvent depending on
the solubility of the sample. The sample was dissolved in the appropriate solvent and a
few drops applied to the disc. Discs were allowed to dry before spectra were recorded.
4.1.4 Ultraviolet spectroscopy
Ultraviolet absorption spectra were recorded on a Varian DMS 300 DV-visible
spectrophotometer with methanol used as solvent. The NaOAc and AICl3 solutions
used for bathochromic shift tests were prepared by dissolving 0.5 g of each salt
(anhydrous) in 100 rnl redistilled methanol.
4.1.5 Mass spectrometry
High resolution (HRMS) and electron impact (ElMS) mass spectra were recorded by Dr.
P. Boschoff at the Cape Technikon on Kratos High Resolution MS 9/50 and a Finnigan
1020 GC MS instruments.
4.1.6 NMR Spectroscopy
NMR spectra were recorded at room temperature on a Varian Gemini 300 MHz
spectrometer. For BC NMR, spectra were recorded at 75.4 MHz. The less concentrated
samples were recorded on a Varian Innova 500 MHz spectrometer. The solvent used
was deuteriomethanol (CD30D) with deuteriochloroform (CDCh) used where
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necessary, e.g. NOE experiments involving peaks that appeared superimposed in the IH
NMR spectrum when CD30D was used as solvent. All 8 values are expressed in ppm
relative to TMS. Peaks due to solvent impurities are marked with a cross (X) on the
respective spectra in which they appear.
4.1.7 Chromatography
4.1.7 a) Column chromatography
For column chromatography, use was made of glass columns (1-4 cm in diameter)
packed with silica gel 60 (particle size 0,040 - 0,063 mm, 230 - 400 mesh ASTM,
Merck Art 9385) and where necessary Sephadex LH-20. In the initial stages of
purification, coarser silica gel (Merck Art 7734) and/or silica gel S 31608 (particle size
0.063-0.1 mm) were used under gravity. Repeated chromatography, either as flash or
under gravity, was performed in order to separate the compounds in the extracts. A
variety of solvent systems were used as eluants. The solvents most used, albeit in
different proportions - depending on the polarity of the compounds to be separated, were
hexane, dichloromethane and ethyl acetate. Mixtures of dichloromethane and methanol
were also used especially for elution of very polar compounds. Flash chromatography
involved the use of pressure to elute the compounds from the column. Final separation
and purification involved use of mini-columns made from pasteur pipettes.
4.1.7 b) Thin and Preparative Layer chromatography
Precoated, aluminium backed silica gel 60 plates (thickness 0,2 mm ; Merck Art 5533)
were used to follow the separation process as well as to detect the composition of the
different fractions collected from the column. After developing the plates in an
appropriate solvent, they were sprayed with anisaldehyde spray reagent. The
anisaldehyde reagent was made by mixing anisaldehyde, cone. sulphuric acid and
methanol in the ratio 1: 2: 80. Spots were observed after heating the developed and
sprayed plate with a heating gun. Spots due to homoisoflavonoids were visualised as
bright yellow to orange in colour while those due to stilbenoids appeared as bright
purple-blue in colour.
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Compounds which were difficult to separate by column chromatography were separated
using preparative TLC. The plates used were commercially available Merck F-254
silica gel plates with indicator. A DV lamp set at 254 nm was used to detect the spots of
the separated compounds.
4.2 Preparation and extraction of plant material
4.2.1 General extraction procedures
Plant material for this project was collected from KwaZulu-Natal and Mpumalanga and
was authenticated by Dr. Neil Crouch of the National Botanical Institute. Voucher
specimens were deposited at the Natal Herbarium. The acronyms KZN for KwaZulu-
Natal and Mpl for Mpumalanga will be used when reference is made to the locality of
collection where appropriate.
Fresh bulbs of Scilla nervosa (Burch.) Jessop [KZN] (1.3 kg) and Scilla natalensis
Planch. [KZN] (1.2 kg) were cut into small chunks, air dried overnight and extracted
for twenty four hours using a Soxhlet apparatus with hexane, ethyl acetate and methanol
successively. A portion of the S. nervosa bulbs (200 g) was soaked in chloroform for 12
hrs. The fractions recovered after solvent evaporation were subjected to column
chromatography.
Fresh bulbs of Scilla nervosa [Mpl], S. natalensis [Mpl], S. dracomontana Hilliard and
Burt and S. kraussii Bak. were subjected to the extraction procedure presented in
scheme 4.1. The bulbs were chopped into small pieces and extracted with methanol (2.5
L) in 5 L conical flasks. The flasks were agitated on a Labcon mechanical shaker at 140
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* - After extraction with the three solvents, i.e. hexane, ether and ethyl acetate, the
aqueous mother liquors of each extract were further extracted with n-butanol (500 ml).
However this polar fraction was put aside for future analysis and does not form part of
the work presented here. The ether and ethyl acetate extracts had, in certain cases,
similar TLC profiles and the researcher used his judgement to choose which one to
investigate between the two.
4.3 Extractives from Scilla nervosa (Burch.) Jessop
Fresh bulbs of Scilla nervosa [KZN] were purchased at the Warwick Triangle herbal
market, Berea, Durban. The voucher specimen number is V.Bangani and N.Crouch 2.
The bulbs were subjected to the procedure as described in 4.2.1 above. The masses of
the different extracts obtained after evaporation of solvent were:
Hexane - 1.5 g
Chloroform - 18 g
Ethyl acetate - 34 g
Methanol - 46 g
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Fresh bulbs of S. nervosa [Mpl] were collected in Lydenburg, Mpumalanga. The
voucher specimen number is Crouch 752. A mass of 950 g of the bulbs was extracted
as presented in scheme 4.1 and section 4.2 above. The masses of the extracts obtained
after evaporation of solvent were:
Crude methanol extract - 260 g : a portion (62 g) of this crude extract was subjected to
the procedure outlined in scheme 4.1 to yield the following extracts:
Hexane extract - 0.94 g
Ether extract - 13 g
Ethyl acetate extract - 24 g
Separation by column chromatography of the hexane extract from S. nervosa [KZN]
yielded compounds (i) and (ii), while the ethyl acetate fraction yielded compounds (Hi),
(iv), (v), (vi) and (vii). The chloroform extract also yielded compound (i) and (ii).
From the hexane extract of S. nervosa [Mpl] compounds (i)and (iv) were isolated by
column chromatography.
Compound (Hi) was isolated from the ethyl acetate extract via an acetylation step.
Acetylation was performed on a mixture (87 mg) of compound (Hi) with another
unknown compound after persistent co-elution despite use of different solvent systems.
A I H NMR spectrum was run prior to acetylation to make sure that none of the
constituents of the mixture have acetyl groups as previous reports have revealed that
acetyl groups do occur in some homoisoflavonoids 15.
The acetylation was carried out - after the I H NMR spectrum revealed no such acetyl
groups.
Acetylation:
The mixture (87 mg) was dissolved in pyridine (5 ml). Acetic anhydride (3 ml) was
added, the mixture was warmed on a steam bath and left to stand overnight under
anhydrous conditions. The excess acetic anhydride was removed by the addition and in
vacuo removal of methanol (10 ml), after which pyridine was removed by addition of
toluene (3 x 10 ml) and azeotropic distillation. The final traces of toluene were removed
by further addition and removal of methanol (3 x Wml). After all the above steps, the
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acetylated mixture was separated using a mini column to provide 12 mg of acetylated
compound (iii).
4.3.1 Physical data for compound (i)
Name: 5,7-dimethoxy-3-(4-methoxybenzyl)chroman-4-one
Yield: 75 mg, 30 mg from the KZN specimen and 45 mg from the Mpl specimen
Physical description: off white vitreous solid
[a]D = _50 0 (c = 0.3 g/ 100 ml, CH30H), lit.value q [synthetic compound] = +12 ± 2 0
26(c 0.227, CHCh)
Mass spectrum: HRMS m/z: 328.1306 [M+] (C19H200S requires 328.1311), ElMS m/z
(rel.int.): 328 [M+] (lOO), 207 (37),181 (35), 180 (61) 148 (26),121 (90) [spectrum 4]
Data for IHand BC NMR spectroscopy is presented in Tables 3.1 and 3.2 in Chapter 3
and [spectra 1 and 2]
IR data: vmax[NaCI](cm-I): 2932 (C-H aromatic and aliphatic stretching), 1686 (C=O
stretching), 1608 (C=C stretching), 1524 (CH2, CH3 bending), 1259, 1041 (C-O
stretching) [spectrum 5]
DV data: Amax nm (log l'» : 283 (4.47) [spectrum 6], lit.value : 283.5 (4.281) 26
Bathochromic shifts: no shift (AICh) [spectrum 7]
no shift (NaOAc) [spectrum 8]
q - negative optical rotation have been reported for most naturally occurring 3-benzyl-4-
chromanones with one exception being 3,9-dihydroeucomin 17
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4.3.2 Physical data for compound (ii)
Name : 5-hydroxy-7-methoxy-3-(3-hydroxy-4-methoxybenzyl)chroman-4-one
Yield: 62 mg
Physical description: light yellow crystals
[a]D = _360(c = 0.55 g /100 ml, CHCh)
Mass spectrum: HRMS m/z: 330.1092 [M+] (C18H1806 requires 330.1093), EIMS m/z
(rel.int.): 330 [M+] (37), 193 (7), 167 (21), 166 (3), 149 (15), 137 (100) [spectrum 12]
Data for IH and 13C NMR spectroscopy is presented in Tables 3.1 and 3.2 in Chapter 3
[spectra 9 and 10]
IR data : vmax[NaCl] (cm-I) : 3461 (O-H stretching, H-bonded), 2953, 2835 (C-H
aromatic and aliphatic stretching), 1645 (C=O), 1581 (C=C stretching), 1515, 1279
(CH2 and CH3 bending), 1168 (C-O stretching) [spectrum 13]
DV data: Amax nm (log e): 288 (4.34) [spectrum 14]
Bathochromic shift: 312 (+AICl)) [spectrum 15]
no shift (+NaOAc) [spectrum 16]
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4.3.3 Physical data for compound (Hi) (as its acetyl derivative)
Name: 5,7-dimethoxy-3-(4-acetoxybenzyl)chroman-4-one
Yield: 12 mg
Physical description: vitreous off white solid
[a]D = 0° (0,0076g / 100ml), a zero optical activity could be due the low concentration
of sample or the compound may have been a racemate.
Mass spectrum: HRMS m/z: 356.1270 [M+] (CZOHZ006 requires 356.1260), EIMS m/z
(rel.int.): 356 [M+] (75), 314 (41), 297 (10), 221 (11),207 (67),181 (63), 180 (100),152
(25), 107 (19), 77 (7) [spectrum 20]
Data for IHand l3C NMR spectroscopy is presented in Tables 3.1 and 3.2 in Chapter 3
and [spectra 17 and 18]
IR data: vmax[NaCI] (cm-I) : 2930, 2857 (C-H aromatic and aliphatic stretching), 1729
(ester group stretching), 1671 (C=O stretching), 1613 (C=C stretching), 1466, 1228
(CHz and CH3 bending), 1165 (C-O stretching) [spectrum 21]
DV data: Amax nm (log 8): 282 (4.17) [spectrum 22]
Bathochromic shift: no shift (+AICI3) [spectrum 23]
no shift (+NaOAc) [spectrum 24]
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4.3.4 Physical data for compound (iv)
Name: 5-hydroxy-7-methoxy-3-(4-methoxybenzyl)chroman-4-one
Yield: 28 mg
Physical description : off white needle shaped crystals
Mp : 81-84 QC, lit. values : 85-87 °c 26, 87-88 °c 56
[a]o = -38 ° ( c = 0.024 g / 100 ml, MeOH), lit.value [synthetic compound] : +23 ± 2 °
26(c 0.218, CHC!))
Mass spectrum: HRMS m/z: 314.1154 [M+] (ClsHlS05 requires 314.1158), EIMS m/z
(rel.int.): 314 [M+] (36),167 (8),166 (5),149 (15),129 (27),121 (100) [spectrum 27]
Data for IH and l3C NMR spectroscopy are presented in Tables 3.1 and 3.2 in Chapter 3
[spectra 25 and 26]
IR data: vrnax[NaCl] (cm-I): 2929,2848 (C-H aromatic and aliphatic stretching), 1655
(C=O), 1578 (C=C stretching), 1518 (CH2 and CH3 bending), 1164 (C-O stretching)
[spectrum 28]
DV data: Amax nm (log E) : 288 (4.43) [spectrum 29], lit. value: 288.5 (4.306) 26
Bathocromic shift: 311 (+AlC!)) [spectrum 30]
no shift (+NaOAc) [spectrum 31]
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4.3.5 Physical data for compound (v)
Name : (E)-5,7-dihydroxy-3-(4-hydroxybenzylidene)chroman-4-one or (E)-4'-O-
demethyleucornin)
Yield: 35 mg
Physical description: fine bright yellow crystals
Mp: 197-201 QC, lit.value =209-213 QC 59
Mass spectrum: HRMS m/z: 284.0678 [M+] (C16H1205 requires 284.0685), ElMS m/z
(reLint.): 284 [M+] (99), 207 (51), 180 (78), 167 (88),153 (lOO), 152 (43), 137 (89), 132
(49), 131 (51), 107 (96), 57 (56),41 (53) [spectrum 35]
Data for IH and 13C NMR spectroscopy is presented in Tables 3.1 and 3.2 in Chapter 3
[spectra 32, 32a, 32b and 33]
IR data vmax[NaCl](cm- l ) : 3384 (O-H stretching, H-bonded), 1642, (C=O stretching),
1605 (C=C stretching), 1514, 1294 (CH2 bending), 1166 (C-O stretching) [spectr. 37]
DV data: Amax nm (log E) : 362 (4.36) [spectrum 38], lit. value =364 (4.47) 59
Bathochromic shift: 402 (+AICi]) [spectrum 39]
374 (+NaOAc) [spectrum 40]
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4.3.6 Physical data for compound (vi)
Name: (E)-3,4',5-trihydroxystilbene or (E)-resveratrol
Yield: 14 mg
Physical description: off white crystals turning to brown on standing
Mp: 263-265 QC, lit.values : 265-267 QC 56,260 QC 89, 253-255 95
Mass spectrum: HRMS m1z: 228.0784 [M+] (C14HI20 3 requires 228.0786), EIMS m1z
(rel.int.): 228 [M+] (100), 227 (24), 211 (16), 181 (23), 157 (13), 137 (25), 129 (IQ),
115 (12), 83 (14), 69 (22), 57 (30) [spectrum 45]
Data for IH and l3C NMR spectroscopy is presented in Tables 3.3 and 3.4 in Chapter 3
[spectra 41a, 41b and 42]
lR data: vmax[NaC1](cm'l) : 3307 (O-H stretching, H-bonded), 2927 (C-H aromatic and
oelifinic stretching), 1599, 1516 (C=C stretching), [spectrum 46]
DV data: Amax nm (log e): 306 (4.12), 320sh (3.83) [spectrum 47], lit.value : 305
(4.02),320 (3.34) 89
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4.3.7 Physical data for compound (vii)
Name: (E)-3,3' ,5-trihydroxy-4'-methoxystilbene or (E)-rhapontigenin
Yield: 12 mg
Physical description: off white crystals turning dark brown on standing
Mp: 189-192 QC, lit.values : 186-187 QC 56,196-197 QC 116
Mass spectrum: HRMS m/z: 258.0903 [M+] (C15H1404 requires 258.0892), ElMS m/z
(rel.int.): 258 [M+] (100),225 (13), 197 (20), 169 (8), 129 (5) [spectrum 52]
Data for IH and l3C NMR spectroscopy is presented in Tables 3.3 and 3.4 in Chapter 3
[spectra 48a, 48b and 49]
IR data: vmax[NaCl](cm- l ) : 3396 (O-H stretching, H-bonded), 2932 (C-H aromatic,
olefinic and aliphatic stretching), 1612, 1523 (C=C stretching) [spectrum 53]
DV data: Amax nm (log E) : 323 (4.57) [spectr. 54], lit.value : 302 (4.49),322 (4.53) 116
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4.4 Extractives from S. natalensis Planch
Fresh bulbs of Scilla natalensis[KZN] (voucher specimen no. V.Bangani and
N.Crouch 1) were also bought at Warwick Triangle herbal market. A mass of 1.2kg of
fresh bulbs was extracted as described in section 4.2.1. The masses of the extracts
obtained were:
Hexane - 2.5g
Ethyl acetate - 12.8g
Methanol - 64g
Fresh bulbs of S. natalensis [Mpl] (1.3kg) (voucher specimen no. Crouch 753)
collected in Lydenburg, Mpumalanga were also subjected to the procedure outlined in
Scheme 4.1 The masses of the extracts obtained were:
Crude methanolic extract - 140g : a portion (28g) of this crude extract was subjected to
the procedure outlined Scheme 4.1 to give the following extracts:
Hexane - 170 mg
Ether - 750 mg
Ethyl acetate - 450 mg
Column chromatography of a portion (5 g) of the methanol fraction of S. natalensis
[KZN] yielded compound (viii) while the ether and the hexane extract from the
Mpumalanga specimen yielded compound (ix).
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4.4.1 Physical data for compound (viii)
Name 5,7-dihydroxy-6-methoxy-3-(4-hydroxybenzyl)chroman-4-one (3,9-
dihydroeucomnalin)
Yield : 34 mg, 19 mg from Scilla natalensis* (KZN) and 15 mg from Scilla
dracomontana
Physical description: yellowish green crystals
Mp: 205-207 °c, lit.value : 207-209 °c 56,61
[a] D = 0°, (0.0087g / 100ml, MeOH), a zero optical activity could be due the low
concentration of sample or the compound may have been a racemate, lit.value : -10°
(dioxan) 56,61
Mass spectrum: HRMS m/z: 316.0945 [M+] (C17HI606 requires 316.0947), ElMS m/z
(rel.int.): 316 [M+] (100),210 (60), 209 (23), 183 (l0), 182 (7), 167 (13), 149 (7), 137
(48), 121 (6), 108 (9), 107 (84), 69 (13) [spectrum 57]
Data for 1H and 13C NMR spectroscopy is presented in Tables 3.1 and 3.2 in Chapter 3
[spectra 55 and 56]
IR data : vmaANaCl](cm-
1) : 3390 (O-H stretching, H-bonded), 2925, 2856 (C-H
aromatic and aliphatic stretching), 1653 (C=O and C=C stretching, signal overlap),
1521,1451,1269 (CH2 and CH3 bending), 1172 (C-O stretching) [spectrum 58]
DV data: Amax nm (log E): 290 (4.63) [spectrum 59], lit. value: 292 (4.61) 61
Bathochromic shift: 312 (+AlC!J) [spectrum 60]
327 (+NaOAc) [spectrum 61]
* - sample lost, only have S. dracomontana sample.
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4.4.2 Physical data for compound (ix)
Name: 5,7~dihydroxy-6-methoxy-3-(3-hydroxy-4-methoxybenzyl)chroman-4-one
Yield: 23 mg
Physical description: vitreous orange-yellow solid
[a] D =-62.5° (c =0.08g/l00ml, CH30H), lit. value: not available 4
Mass spectrum: HRMS m/z: 346.1044 [M+] (ClsHlS07 requires 346.1052), EIMS m/z
(rel.int.): 346 [M+] (39), 209 (2), 137 (lOO), 122 (5) [spectrum 64]
Data for 1Hand l3C NMR spectroscopy is presented in Tables 3.1 and 3.2 in Chapter 3
[spectra 62 and 63]
IR data: vmax[NaCl](cm-1) : 3422 (O-H stretching, H-bonded), 2938, 2849 (C-H
aromatic and aliphatic stretching), 1653 (C=O stretching), 1595 (C=C stretching), 1519,
1277 (CH2 and CH3bending), 1169 (C-O stretching) [spectrum 66]
DV data: Amax nm (log 8) : 292 (4.69) [spectrum 67], lit. value: not available 4
Bathocromic shift: 315 (+A1Ch) [spectrum 68]
328 (+NaOAc) [spectrum 69]
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4.5 Extractives from Scilla dracomontana Hilliard and Burtt.
Fresh bulbs of Scilla dracomontana (1.2 kg) (voucher specimen no. N.Crollch and
V.Bangani 754). collected from the Bamboo mountain district near Underberg in the
KwaZulu-Natal Drakensberg were subjected to the same procedure as outlined in
scheme 4.1. The masses of the extracts obtained were:
Hexane - 420 mg
Ether - 4.5 g
Ethyl acetate - 6.8 g
Column chromatophic separation of the hexane extract yielded compound (x) while
preparative TLC of the ether extract yielded compounds (viii) and (xi)
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4.5.1 Physical data for compound (x)
Name : 5,7-dihydroxy-6-methoxy-3-(4-methoxybenzyl)chroman-4-one
Yield: 28 mg
Physical description: vitreous yellow solid
[a]D = _1000 (c = 0.025 g /100 ml, CH30H)
Mass spectrum: HRMS m/z: 330.1100 [M+] (C17HIS0 6 requires 330.1103), ElMS m/z
(rel.int.): 330 [M+] (32), 167 (6), 149 (6), 121 (lOO), 77 (7) [spectrum 73]
Data for 1Hand l3C NMR spectroscopy is presented in Tables 3.1 and 3.2 in Chapter 3
[spectra 70 and 71]
IR data : vmax[NaCl] (cm-I) : 3375 (O-H stretching, H-bonded), 2940, 2850 (C-H
aromatic and aliphatic stretching), 1655 (C=O stretching), 1591 (C=C stretching), 1527,
1464, 1306 (CH2 and CH3 bending), 1171 (C-O stretching) [spectrum 74]
DV data: Amax nm (log E): 293 (4.58) [spectrum 75]
Bathochromic shift: 312 (+AlCh) [spectrum 76]
327 (+NaOAc) [spectrum 77]
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4.5.2 Physical data for compound (xi)
Name: 3,5,7-trihydroxy-3-(4-methoxybenzyl)chroman-4-one (eucomol)
Yield: 12 mg
Physical description: greenish yellow crystals
Mp: 131-133 QC, lit.value = 134.5-135 QC 56.62
[a]D = sample too dilute, could not obtain angle of rotation, lit.value =-32 Q(CHC!])
56,62
Mass spectrum: HRMS mlz: 316.0940 [M+] (C\7H1606 requires 316.0947), ElMS mlz
(rel.int.): 316 [M+] (7),195 (4),137 (7),121 (lOO) [spectrum 82]
Data for IH and l3C NMR spectroscopy is presented in Tables 3.1 and 3.2 in Chapter 3
and [spectra 78 and 79]
IR data: vmax[NaCl](cm'l) : 3489 (O-H stretching, H-bonded), 2929 (C-H aromatic and
aliphatic stretching), 1653 (C=O stretching), 1590 (C=C stretching), 1516 (CH2 and CH3
bending), 1169 (C-O stretching) [spectrum 83]
DV data: Amax nm (log e): 291 (4.45) [spectrum 84], lit. value: 293 (3.29)* 62
Bathocromic shift: 312 (+AICI3) [spectrum 85]
327 (+NaOAc) [spectrum 86]
* - probably recorded erroneously as literature log e values lie in the range 4.2 to 4.7 \7.
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4.6 Extractives from Scilla kraussii Bak.
Scilla kraussii was collected near Umtamvuna close to Port Edward on the KwaZulu-
Natal south coast. Fresh bulbs (1.3 kg) were also subjected to the procedure as
presented in scheme 4.1. The voucher specimen number is N. Crouch and D.
Mulholland 770. The masses of the extracts were:
Crude methanolic extract - 130 g : a portion (48 g) of the crude methanolic extract was
subjected to the procedure outlined scheme 4.1 to give the following extracts:
Hexane -18 mg
Ether - 90 mg
Ethyl acetate - 150 mg
The hexane extract was noticed to be rich in fatty acids and thus not investigated. The
ethyl acetate extract had a similar TLC profile as the ether extract. The ether extract was
chosen for investigation. On chromatographic separation the ether extract yielded
compound (xii).
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4.6.1 Physical data for compound (xii)
Name : 5,7-dihydroxy-3-(3-hydroxy-4-methoxybenzyl)chroman-4-one
Yield: 24 mg
Physical description: vitreous light yellow solid
[a]D =_58 0 (c =0.065 g / 100 ml in MeOH), lit. value: _34 0 (c 004, MeOH) 2
Mass spectrum: HRMS m/z: 316.0952 [M+] (C17H1606 requires 316.0947), EIM:S m/z
(rel.int.): 316 [M+] (31),137 (lOO), 122 (6) [spectrum 90]
Data for IH and 13C NMR spectroscopy is presented in Tables 3.1 and 3.2 in Chapter 3
[spectra 87 and 88]
IR data: Vmax [NaCI](cm-
1
) : 3403 (O-H stretching, H-bonded), 2923, 2847 (C-H
aromatic and aliphatic stretching), 1638 (C=O stretching), 1600 (C=C stretching), 1517,
1274 (CH2 and CH3 bending), 1165 (C-O stretching) [spectrum 91]
DV data: Amax nm (log E): 290 (4.37) [spectrum 92], lit. value: 287 (4.22) 2
Bathochromic shift : 313 (+AICI3) [spectrum 93]
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23 3'-O-methylsappanol and/or 3'-O-methylepisappanol
24 3'-deoxysappanol
25 4-0-methylsappanol and/or 4-0-methylepisappanol
26 3'-deoxy-4-0-methylsappanol

















































































































23 3'-O-methylsappanol and/or 3'-O-methylepisappanol
24 3'-deoxysappanol
25 4-0-methylsappanol and/or 4-0-methylepisappanol
26 3'-deoxy-4-0-methylsappanol

























































































Cpd Spectrum no. Type of spectrum Pa~e
(i) 1 IHNMR SI





7 DV (+ AICh)* S5
8 DV (+ NaOAc)* S5
(H) 9 IHNMR S6
10 13CNMR S7
lla NOE S8




15 DV (+ AICh)* SII
16 DV (+ NaOAc)* SII






23 DV (+ AICh)* S16
24 DV (+ NaOAc)* S16





30 DV (+ AICh)* S21
31 DV (+ NaOAc)* S21
(v) 32a IHNMR S22










39 DV (+ AICh)* S29
40 DV (+ NaOAc)* S29
(vi) 41a IHNMR S30







(vii) 48a IHNMR S36














60 DV (+ AICh)* S47
61 DV (+ NaOAc)* S47
(ix) 62 IHNMR S48







68 DV (+ AICh)* S53
69 DV (+ NaOAc)* S53








76 DV (+ AICh)* 559
77 DV (+ NaOAc)* 559
(xi) 78 I HNMR 560






85 DV (+ AICh)* 565
86 DV (+ NaOAc)* 565






93 DV (+ AICh)* 570
94 DV (+ NaOAc)* 570
* - Where there is bathochromic shift, the spectrum on the right in each profile is
the one indicating the shift while the one on the left is the normal spectrum of the
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Spectrum 19 : ADEPT spectrum of compound (iii) acetate
SCAN GRAPH. Flaggjog=Mlz.
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Spectrum 21 : IR spectrum of compound (iii) acetate
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Spectrum 28 : ill. spectrum of compound (iv)
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Spectrum 29 : DV spectrum of compound (iv)
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Spectrum 3~ : COSY spectrum of compound (Y)
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Spectrum 36a: NOE spectrum of compound Cv)
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Spectrum 44 : COSY spectrum of compound (vi)
SCAN ORAP... FlagglngDM/z.






Spectrum 45 : Mass spectrum of compound (vi)
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Spectrum 51 c : NOE spectrum of compound (vii)
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Spectrum 60 : DV and DV (AlCb) spectra of compound (viii)
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Spectrum 68 : DV and DV (+ AIeL) spectra of compound Cix)
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Spectrum 723: NOE spectrum of compound (x)
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Spectrum 72b: NOE spectrum of compound (x)
SCAN GRAPH. Flagglng=M/z.
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Spectrum 81 : HETCOR spectrum of compound (xi)
SCAN GRAPH. Flagu1ng=Mlz.
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Spectrum 84 : UV'spectrum of compound (xiJ
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Spectrum 89: NOE spectrum of compound (xii)
ISCAN GRAPH. Flayglng=MIz..
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Spectrum 93 : DV and DV (+ AIeL) spectra of compound (xii)
















Spectrum 94 : DV and DV (+ NaOAc) spectra of compound (xii)
